Browse by Track

(T0930-09-51) Novel Pharmacokinetic and Hematological Monitoring Methods Validated for Small Volume Blood Sampling for Gene or Cell Therapies

(T0930-09-54) A Generic Approach to Monkey Anti-drug Antibodies Assay Development for Antibody Therapeutic Preclinical Studies

(M1230-09-49) Combining Acoustic Liquid Handling with the Gyros Immunoassay Platform for Bioanalysis of Therapeutic Antibodies in Small Volume Samples

(M1230-09-50) Development of a Bridging ECL Method for the Detection of Anti-Drug Antibodies in Human Serum on an Automated System

(M1230-09-51) Improving Sensitivity and Separation of Multiple Nucleotides Utilizing a Metal Free UHPLC System

(M1230-09-52) Ranking mAb-excipient Interactions in Biologics Formulations by NMR and Molecular Dynamics

(M1230-09-53) Assessment of Alternative Fit-for-Purpose Strategies for Non Affinity-Based LC-MS Quantitation of Target Proteins in Biological Matrices

(T1430-09-51) Comparability of Glycosylation, Antigen Binding and Fc Effector Function for Three Anti-TNF-a Therapeutics

(M1430-09-52) Regulated qPCR Validation and qPCR/ddPCR Cross-Validation

(M1430-09-53) Development of a Generic Assay Platform Using Human IgG Light Chain-Specific Antibody Reagents for Concentration Measurement of Antibody Therapeutic in Preclinical Studies

(T0930-09-49) Validation of Ultra-High Sensitive SIMOA Assays for the Quantitation of Neurofilament Light Chain (NF-L) and Glial Fibrillary Acidic Protein (GFAP)

(T0930-09-53) Development and Validation of a Human Soluble MICA Biomarker Assay for use in Clinical Studies

(M0930-09-54) Quantitative Expression of Stemness Markers to Identify Metastatic Potential of Triple-Negative Breast Cancer Cells: Prognostic Signature for Personalized Treatment

(T1130-09-51) Circulating Tumor Cells as a Biomarker for Evaluating Tumor Progression and Treatment Response in Patients with Gastrointestinal Malignancies

(M1130-09-52) NOHA: A Novel Biomarker to Monitor Treatment Outcome in Triple-Negative Breast Cancer Patients

(M1530-09-50) Design of Total VEGF Assay Provides Simple Data Interpretation of Anti-VEGF Therapeutic Study

(M1530-09-51) Validation of IL-1RA and IL-2Rα Biomarker Multiplex ECL Assay to Increase Efficiency and Quality in Supporting Inflammatory Biomarker Studies

(M1530-09-52) Validation of a High-Sensitivity Inflammatory Cytokine Panel to Improve Clinical Biomarker Data Utility

(M1530-09-53) Development of an Extractionless, Multiplexed Assay for the Direct Detection of miRNAs in Liver Tissue

(M1530-09-54) Challenges in Development of Multiplex Biomarker Assays for Neurodegenerative Diseases

(M0930-09-50) Robustness Testing of an Assay for Flow Cytometric CAR Persistence Determination

(M1130-09-51) Development and Validation of an LC-MS/MS Method for Determination of Difelikefalin in Human Plasma

(T1230-09-49) Validation of an MFLC-MS/MS Assay for the Quantitative Analysis of a Novel Peptide, AT-01, Extracted from K₂EDTA Plasma

(T1230-09-51) Direct Monitoring of DNA Plasmid Concentration and the Extent of Plasmid-Liposome Complexation Using 2^nd Derivative Fiber-Optic UV Spectroscopy

(T1230-09-52) A Sensitive Solution for Quantification of Anti-sense Oligonucleotides (ASOs) in Rat Plasma Using High-Resolution Mass Spectrometry

(T1230-09-53) Novel LC-MS/MS Analyses for Glucagon-Like Peptide-1 (GLP-1) Analogs, Liraglutide, Lixisenatide, and Semaglutide, and Pharmacokinetic Evaluation in Rats

(T1430-09-52) Hybrid-LC-MS/MS Method for Simultaneous Quantification of Two COVID-19 Biotherapeutic Monoclonal Antibodies in Human Serum

(T1530-09-50) Pharmacokinetics and Brain Distribution of the Therapeutic Peptide Semaglutide by a Novel Liquid Chromatography-Tandem Mass Spectrometry

(T1530-09-51) Novel HILIC-LC-MS Method for Quantification of Ketone Bodies (beta-hydroxybutyrate and acetoacetate) in Human Plasma

(T1530-09-52) Impact of Autosampler Design on Carryover Performance During Method Migration

(T1530-09-53) Quantitating the Concentration of DNA Plasmid Using 2^nd Derivative Fiber-Optic UV Spectroscopy and Intercalating Dye

(T1530-09-54) Sensitive Bioanalysis of Anti-sense Oligonucleotides through Mitigation of Non-specific Binding and Improved LC-MS/MS Performance

(W1030-09-49) An Evaluation of the Effect of Duplicate- and Single- Well Analyses on Assay Cut Point Calculations and Characterization Experiments in Preclinical Immunogenicity Assays

(W1030-09-50) Challenges and Solutions for Successful Generation of Anti-Drug Antibody (ADA) Positive Control (PC) for Development of ADA assay for STK-001 in Monkey and Human Serum

(M1430-09-50) De Novo Development and Validation of a Flow Cytometry Method for the Detection of Neutralizing Antibodies against Adeno-Associated Virus Serotype 5 (AAV5)

(T1430-09-50) Toward the Use of In Vitro Animal Matrix Stress Models to Predict In Vivo Stability of Oligonucleotides

(W0930-09-49) Rapid Analysis and Characterization of Lipid Nanoparticle Components for mRNA Delivery

(M0930-09-52) Characterization of Lipid Nanoparticle (LNP) Composition UHPLC-CAD

(W0930-09-53) Preclinical Evaluation of Pharmacokinetic, Receptor Occupancy, and Immunogenicity Profiles of a Bispecific Antibody Construct in a Monkey Study

(W1030-09-51) Optimizing ADC Separations: Advantages of Bio-Compatible Versus Stainless Steel UHPLC Systems

(W1030-09-52) Generation of Rabbit Anti-Peptide Monoclonal Antibodies for Microdystrophin and Dystrophin Quantitation

(T1430-09-53) Comprehensive AAV Characterizations Using HRMS: Peptide Mapping, Capsid Proteins, Intact ssDNA, and Intact Virus

(M1130-09-49) Nanoparticle-Mediated Delivery of miRNA Mimics for Gene Therapy

(W1030-09-53) Prediction of Frozen Virus Stability Based on Protein Degradation Mechanisms, Real-Time Data of Representative Viruses, and Data Modeling

(M1130-09-54) Bridging Two Generations of Commercial ELISA Kits for Residual Vero Cell Host Cell Protein (HCP) Control in Live Virus Vaccines

(W0930-09-52) Development and Validation of Chiral HPLC Method for Quantification of L(-) and D(+) Epinephrine in Autoinjectors

(T1130-09-50) Effects of Brij^® O20 as a Solubilizer and Stabilizer in Support of In Vitro Permeation Testing for Topical Dermatological Formulations

(T0930-09-50) Evaluation of the Tasso-M20 Microsampling in Support of Clinical PK Studies

(M0930-09-51) An Emerging Derivatization Strategy for Minimizing Matrix Effect in Metabolomics Analysis

(M1030-09-49) A Simple, Rapid Method for Simultaneous Quantitative Analysis of Dithiothreitol and Dihydroxy-1,2-dithiane in Cell Culture Media by LC/MS/MS

(M1030-09-50) Development of an Automated and High Throughput UHPLC/MS Based Workflow for Cleaning Verification of Potent Compounds in the Pharmaceutical Manufacturing Environment

(M1030-09-51) Innovative Application of ICP-MS Technology in Discovery and Early Development of Radioligand Therapeutics

(M1030-09-52) Overcoming Quantitative Challenges in Bioanalysis of Small Molecules Using the MRM³ and Q0 Dissociation Approaches on the SCIEX 7500 System

(M1030-09-53) Development of Rapid LC-MS-MS Method for Therapeutic Monitoring of Plazomicin in Human Plasma

(M1030-09-54) Quantitative Analysis of levo-alpha-acetyl-methadol (LAAM) in Rabbit Plasma for A Pharmacokinetic Study of Multiple Dosage Forms

(T1330-09-50) Quantitative Determination of Arsenic in Dog Blood and Human Blood by Inductively Coupled Plasma Mass Spectrometry (ICP-MS) for Arsenic Drug Development in Pre-Clinical and Clinical Studies

(M0930-09-49) Comparative Study of Protein Precipitation, Solid-Phase Extraction and Phospholipid Removal for Simultaneous Quantification of Serotonin, Dopamine, and Norepinephrine by LC-MS/MS in the Mouse Brain

(T1330-09-51) Laboratory Validation of a Neurofilament Light Chain (NfL) Clinical Trial Assay for Applications in Neurological Diseases Testing Services

(T1430-09-54) A Targeted LC-MS/MS Method for Quantitative Tissue Distribution Analysis (QTDA) of Metabolomics in Tumors using Laser Microdissection

(W0930-09-50) Development and Validation of a Blood Micro Sampling Methodology to Facilitate Conduct of Pharmacokinetic Studies in Pregnant and Postpartum Patients

(W0930-09-51) LCMS-MS Method Development and Detection Challenges of low Molecular Weight Hydrophobic Topical Dermatological Products in Support of In Vitro Permeation Testing (IVPT)

(M0930-09-53) Evaluation of Gender Differences in Mycophenolic Mofetil-Induced Gastrointestinal Toxicity in Rats using a Novel LC-MS/MS Method

(T1130-09-49) Bioanalytical Considerations in ANDAs with Analyte(s) as Endogenous Compounds Based on Commonly Observed Deficiencies

(M1130-09-50) Volumetric Absorptive Microsampling Method as a Better Blood Sampling Tool for the Therapeutic Drug Monitoring of Everolimus in Liver Transplant Recipients

(T1130-09-52) Development of a Robust and Sensitive Microflow LC-MS/MS Workflow for the Analysis of Oligonucleotides

(M1130-09-53) Comparing Chromatic and Fluorometric Methods for Gentamicin Sulfate Detection by Ninhydrin Complexing and o-phthaldialdehyde Reagent

(T1330-09-52) Comparative Evaluation of Colorimetric, Chromatographic, and Electrochemical Techniques for Hydrogen Sulfide Quantification

(T1330-09-53) Achieving the Ultimate Laboratory Flexibility with a Four Channel Multi-Method Enabled Multiplexing Liquid Chromatography Mass Spectrometry Platform

(T1330-09-54) Improvements in Sensitivity for Bioanalysis of Warfarin Using a Prototype Tandem Quadrupole Mass Spectrometer

(T1130-09-53) Sensitivity Improvement for the Quantitation of Antisense Oligonucleotides in Plasma Using Hybridization Microflow LC-MS/MS

(M0930-11-61) Cannabidiol Loaded Extracellular Vesicles from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Paclitaxel Induced Peripheral Neuropathy

(M1130-11-61) Systematic In Silico Analysis of Clinically Tested Drugs for Reducing Amyloid-Beta Plaque Accumulation in Alzheimer's disease

(M1230-11-64) Implementation of Solid Phase Extraction Acid Dissociation (SPEAD) Methodology in Reconciling Drug Tolerance Demands of Immunogenicity

(T0930-11-61) Cannabinoids Selectively Alter Cytochrome P450(CYP) Activity in Primary Cultures of Human Hepatocytes

(T1430-11-62) MRP1 Knockdown in NCI-H441 Cells to Generate an Organotypic In Vitro Model for Pulmonary Drug Disposition Studies

(T1130-11-62) A Quantitative Systems Pharmacology (QSP) Model to Predict Kinetics of TCR-Engineered T Cell Therapies in Solid Tumors

(M1230-11-65) Anti-inflammatory Effects of Bone-Targeted Angiotensin1-7 Delivery in Adjuvant Arthritic Rat Model

(T1330-11-61) System Optimization to Mitigate Signal Suppression While Autonomously Running Multiple LC/MS/MS Methods in for SiRNAs, Peptides and Small Molecules in Sequence

(W0930-11-61) Setting up Success in the Clinic through Semi-mechanistic Translational Modelling

(M0930-11-62) Efficacy Difference of Antipsychotics in Alzheimer's Disease and Schizophrenia: Explained with Network Efficiency and Pathway Analysis Methods

(T0930-11-62) Exploration of Predictive Bioequivalence: Comparison of Methods to Incorporate In Vitro Dissolution Data in Pharmacokinetic Modeling of BCS Class II Acidic Drugs

(T1130-11-61) A Computational Semi-mechanistic Pharmacology Model of ATG101, a PD-L1/4-1BB Bispecific Antibody for Treatment of Solid Tumors

(M1330-11-62) ILDsym^®, a Quantitative Systems Pharmacology (QSP) Platform, Successfully Simulates the Pathophysiology of Systemic Sclerosis-Interstitial Lung Disease (SSc-ILD) and Inter-patient Variability

(M1530-11-62) Mathematical Modeling to Optimize Dosing Schedules for COVID-19 Vaccines

(T1530-11-63) A Platform for Mechanistic Modelling of Subcutaneous Administration with the Effect of Immunogenicity within the Open Systems Pharmacology Framework

(M1530-11-63) A Population Pharmacokinetic Modeling Approach in Determining the Absolute Bioavailability of Sibeprenlimab, an IgG2 Monoclonal Antibody, from Two Single Ascending Dose Trials in Healthy Subjects

(M1530-11-64) Use of Quantitative Systems Toxicology (QST) to Identify Potential Intrinsic Mechanisms of Toxicity

(M1530-11-65) Population Pharmacokinetic Modeling of Encapsulated Dexamethasone Sodium Phosphate in Autologous Erythrocyte (EryDex system) in the Treatment of Ataxia Telangiectasia

(M1130-11-65) A Retrospective Study of Mid-review Cycle Meetings (MRCMs) within Generic Drug User Fee Amendments (GDUFA) II

(T1530-11-64) Quantifying the Disparate Impact of Eligibility Criteria on Recruiting Diverse Patients for a Clinical Trial in Non-Hodgkin’s Lymphoma

(W0930-11-62) Disposition and Metabolism of [¹⁴C]-Tirzepatide following Subcutaneous Administration in Healthy Male Participants

(T1330-11-62) Regulatory Assessments for In Vivo Pharmacokinetic Abuse Deterrence Studies in Generic Drug Product Applications

(M0930-11-63) Evaluation of Phosphorylated Neurofilament Heavy Chain (pNF-H) as a Biomarker to Bridge Riluzole Treatment and Motor Outcomes in Patients with Acute Spinal Cord Injury (SCI)

(M1230-11-61) Quantitative Liver Function Test for Nonalcoholic Fatty Liver Disease

(M1130-11-62) An Integrative Deep Learning Model to Identify Important Lab Tests from Electronic Medical Records for the Prediction of Suicide-Related Events Among Post-Traumatic Stress Disorder Patients

(M1330-11-63) Quantitative Analysis to Discriminate Cutaneous Pharmacokinetic Profiles for Topical Drug Products

(T1130-11-63) Prediction of Rifampin Exposure Using a Single Concentration Point in Patients with Tuberculosis

(M1230-11-62) Formulation and Taste Assessments in First in Human Studies–Evolving beyond Safety, Tolerability, and Pharmacokinetics

(M1230-11-63) Single-Dose Pharmacokinetics of Intranasal Amiloride in Healthy Volunteers

(T1330-11-63) A Novel Transcellular Assay for Monocarboxylate Transporter 10 (MCT10)

(T1430-11-63) Development of Accelerated Transdermal Diffusion model for In Vitro Permeation Testing of Topical Pharmaceuticals

(T1430-11-64) SARS-CoV-2 Infection Dysregulates Drug Metabolism and Transport

(W0930-11-63) Biorelevant Dissolution and PBPK Modelling to Forecast Oral Absorption – Enabling Formulations for Corallopyronin A

(T0930-11-64) Cost-Effective Strategy - An Innovative Approach Assessing the Drifting Bioavailability of Fixed-Dose Combination Formulations

(W0930-11-64) Using PBPK Modeling in Risk-Assessment of Abuse-Deterrent Formulations

(M0930-11-65) A Mechanistic PBPK Model for Maraviroc to Elucidate the Dose Related Non-Linearity in Oral Absorption using a Middle-Out Approach

(M1130-11-63) Physiologically Based Pharmacokinetic (PBPK) Modelling of Cabotegravir to Evaluate the Feasibility of Drug Delivery via Microarray Patches for the Treatment of HIV in Children

(M1130-11-64) Assessing the Impact of Excipient and Food Intake on Bioequivalence Using PBPK and Virtual Bioequivalence Trial: A Case Example with Acyclovir Immediate Release Tablets

(T1130-11-64) Physiologically Based Pharmacokinetic Modelling to Predict the Pharmacokinetics of Aspirin and Its Metabolite Salicylic Acid after Intravenous, Oral, and Rectal Administration

(T1330-11-64) Physiologically Based Pharmacokinetic Model for Miltefosine in Mice

(M1330-11-64) Prediction Accuracy of Allometrically Scaled VLX-1005 Pharmacokinetics

(T1530-11-61) Physiologically-Based Pharmacokinetic Model to Predict Milk Drug Concentrations of Breast Cancer Resistance Protein Substrates

(T1530-11-62) Effect of Intestinal Precipitation on Cinnarizine Plasma Profile in Fasted State Employing Biorelevant In Vitro Tools and GastroPlus^® Modeling

(M1330-11-65) The Impact of Back Conversion of Acyl Glucuronide Metabolites on the Bioequivalence Studies Submitted in Abbreviated New Drug Applications

(T0930-11-65) Metformin Treatment or Cotreatment with Statins Pharmacokinetics and Pharmacodynamics on Diabetes Patients Before or Post Gastric Bypass Surgery

(T1130-11-65) Pharmacokinetics of LLP2A-Alendronate following Ascending Intravenous Dosing to Patients with Osteopenia Secondary to Glucocorticoids

(T1330-11-65) Influence of Formulation Factors on Potency of Topical Corticosteroid Creams by Fitting Pharmacodynamic Data to the E_max Model

(T1430-11-61) SNP-630, a Novel Compound with Multiple Mechanisms, Reverses Non-alcoholic Steatohepatitis-Derived Liver Injury and Fibrosis

(M0930-05-25) Analysis of DBS Microsamples in a Validated Serum Method

(M1030-05-25) Screening of FDA-Approved Drug Library against Vancomycin Resistant Enterococci

(M1430-05-25) Dynamic Monitoring of Cancer Cell Growth in Monolayer and 3D Spheroid Cultures by Fluorescence – Correlation with Volume, Cell Viability, and Cellular Protein Measurements

(W0930-05-25) Osteoclast Differentiation Is Controlled by KLF2 through the Regulation of Mitochondrial Dysfunction

(T0930-05-25) Understanding the Efficacy of Gemcitabine and Paclitaxel on Desmoplastic Pancreatic Cancer Spheroids

(T0930-10-55) Differential Gene Expression of Human Brain Endothelial Cells Compared to Endothelial Cells Co-cultured with Pericytes

(W0930-10-55) DNA-Based cGAS Agonists as a Novel Approach to cGAS-STING Activation for Cancer Immunotherapy

(M0930-10-55) Vocacapsaicin (formerly CA-008): A Water-Soluble Prodrug for Rapid Release of Capsaicin for the Treatment of Post-Surgical Pain

(W1030-05-25) CD133-Positive Dermal Papilla Cells are a Major Driver of Hair Follicle Neogenesis

(T1030-05-26) Immortalization and Functional Screening of Human Antibody Repertoires from Chronic HIV-1 Infected Patients

(M1030-05-26) The Tumor Microenvironment in Three-Dimensions: Immune Cells, Cytokines, and Tumor Invasion

(W1030-10-55) Seeking Novel Drug Targets for Anti-Metastasis Treatment

(T1130-05-25) Interaction with Macrophages Alters the Susceptibility of Cancer Cells to Ferroptosis

(W1130-05-26) Empty Capsids can Enhance the Transduction Efficiency of AAVs by Inhibiting the Effect of NAbs

(M1130-10-55) Combination of Thymoquinone and Curcumin Induces Cell Death by Alteration of Redox Homeostasis in A375 Melanoma Cell Line

(T1130-10-55) The Mechanisms Governing the Positive Feedback Loop between Cerebrovascular Inflammation and Amyloid Beta Accumulation

(T1230-05-25) Applying Conformational Dynamics in the Evolution of Enzymes for Biocatalysis

(T1230-05-26) 5' Untranslated Region Secondary Structures and Antisense Oligonucleotides Regulate mRNA Translation

(T1230-10-55) Insulin-Like Growth Factor 1 Modulates Transport Activity, Protein Expression, and SUMOylation of Human Organic Anion Transporter 4 through Protein Kinase B Signaling Pathway

(M1230-10-56) A Targeted Approach to Studying DNA Methylation in Individuals with Bipolar Disorder and Suicidal Behavior

(T1230-10-56) Liver-Specific Coactivator ARGLU1 is Required for Selected In Vivo PPARα-Regulated Pathways

(M1330-05-25) Internalization and Trafficking Pathway of T-Cell Receptor Mimic Antibodies (TCRm) RL6A in Human Brain Endothelial Cells at the Blood Brain Barrier (BBB)

(T1330-05-25) Role of Cancer-Associated Fibroblasts in Lung Cancer Chemoresistance

(M1330-10-55) Do We Emit Drugs through Our Skin?

(T1330-10-55) TP53 Codon 72 Polymorphism Modulates Macrophage Polarization through Altered PI3K/Akt Signaling Pathways

(T1430-10-55) Development of a Novel Tocotrienol Analogue, Tocoflexol, as a Powerful Radioprotective Agent

(T1530-05-25) Chloroquine, Hydroxychloroquine Modulates Protein Expression, Transport Function and Ubiquitination of Organic Anion Transporter 3

(T1530-05-26) In Vitro Models of the Human Oral Mucosa for Screening Novel Formulations and Adjuvants for Film-Based Vaccines

(M1530-10-55) Time-Restricted Feeding Protects Fruit Flies from Anoxic Stress via Up-Regulating Expression of Genes Involved in Fat Metabolism and Oxygen Sensing

(M1530-10-56) Leishmania Donovani CYP51 and CYP5122A1 Have Different Biochemical Roles in the Ergosterol Biosynthesis and Display Distinct Inhibition by Antifungal Azole Drugs

(M0930-05-26) Distinguishing Tobacco-Derived Nicotine from Synthetic Nicotine in Commercial Nicotine Samples

(W1030-05-26) Studying the Effect of Increased Modifier Range on EPSA Analysis by SFC

(T1130-05-26) Developing a Dual Prodrug for Triggered Antibiotic Activation

(M1130-05-26) Hit to Lead Optimization Studies of Meta Substituted Enaminone Derivatives as Potential Anti-Seizure Agents for Generalized and Drug-Resistant Epilepsy

(M1330-05-26) The Cationic Antimicrobial Peptide, D-LAK-120A, as a Potential Anti-cancer Therapeutic for Non-small Cell Lung Cancer (NSCLC)

(T1430-10-56) Increasing the Productivity of Oligonucleotide Purification through Column Scaling and Method Optimization

(W0930-05-26) Physiologically Based Pharmacokinetic (PBPK) Modeling of Rifampicin and Its Application for Drug-Drug Interaction with Midazolam in Adults

(T0930-05-27) Viral Mimicry NanoVaccine Boosting B Immunity to Enhance Anti-cancer Efficacy

(M0930-05-28) Therapeutic Anticancer Efficacy of Intra-Tumoral Controlled Osmotic-Driven Delivery of Bioactive IL-2 Using Novel Visible-Light Photocured Biodegradable Injectable Elastomeric Implants

(W0930-05-29) Enhanced U-87 Glioblastoma Cell death by PLGA-PEG Encapsulated Paclitaxel Nanoparticles

(T0930-10-56) An End-to-End Method for AI-Driven Peptide Vaccine Formulation and Translation through Deep Learned Exosome Precision Drug Delivery

(M0930-10-56) Bioengineered Extracellular Vesicles (EV) Enhance Innate EV Mitochondrial Load and Mitochondrial Functions in Ischemic Brain Endothelium

(W0930-10-56) Ethyl Cellulose Coated Polymeric Microneedles for the Controlled Delivery of Drugs

(W0930-10-57) Biodegradable Electrospun Nanofibrous Scaffolds for Retinal Tissue Engineering: Fabrication and Characterization

(T0930-10-57) Pharmacokinetic-Pharmacodynamic Modeling of the Antinociceptive Effect of Mitragynine, the Most Abundant Kratom Alkaloid in Mice

(M0930-10-57) Targeted Liposomes for Selective Delivery of Cisplatin to Ovarian Cancer

(T1030-05-27) Dendrimer Conjugated nSMase2 Inhibitor (D-DPTIP) as a Novel Treatment for Alzheimer’s Disease

(W1030-05-27) Optimization of Spray-Drying Parameters for Formulation Development at Preclinical Scale

(T1030-05-28) Sex Difference of Glucose Transport in an Alzheimer’s disease Transgenic Mouse Model

(M1030-05-28) Solubility Prediction Using Manifold Embedding of Molecular Surface

(W1030-10-57) In Silico Tuning of API for Liposomal Drug Delivery

(W1130-05-25) Exploring the Use of Kinetic pH Calculation to Correct the ACAT Model with a Single Stomach Compartment Setting: Impact of Stomach Setting on Food Effect Prediction for Basic Compounds

(T1130-05-27) Development of a Delayed Release Softgel Dosage Form

(W1130-05-27) Engineering and Optimization of 3D Printed Parenteral Implants

(M1130-05-27) Novel Materials and Formulations for Driving Intracellular Delivery of Macrocyclic Peptides

(M1130-05-28) CNS Distributional Kinetics of Panobinostat in the Mouse Models

(M1130-05-30) Intravitreal Infusion of Drugs Using Eudragit Coated Microneedles

(M1130-10-56) Screening of Significant Molecular Descriptors Affecting Particle Size: A Smart Exemplary to Developing Efficient Lipid-Based Delivery Systems in Pre-formulation Studies

(M1130-10-57) Development and Verification of Physiologically-Based Pharmacokinetic (PBPK) Model for Vaginal Administration of Dapivirine Ring and Gel Formulation

(T1130-10-57) Studying Protein Interactions Under Hydrodynamic Stress

(T1230-05-27) Neutrophil Extracellular Traps (NETs) Targeting Strategies with Monoclonal Antibody (2C5)

(T1230-05-28) Discovery of Peptides to Target Lung Epithelia from Cystic Fibrosis Patients

(M1230-10-57) Correlating In Vitro and In Vivo Performance of Low-to-High Drug Load Amorphous Spray-Dry Dispersions

(T1230-10-57) Potentiating mRNA Delivery through Optimization of Novel Ionizable Lipid Formulations

(T1230-10-58) AI/ML-Driven In Silico Modeling of the COVID-19 Infection for Accelerated Drug Repurposing and Personalized Therapy

(M1230-10-58) Evaluation of Niclosamide as a Repurposed Adjuvant for Treatment of Extensively Drug-Resistant Burkholderia cepacia Complex Infections

(T1330-05-26) Transdermal Delivery of Nicotinamide Mononucleotide Using Dissolvable Microneedles as a Possible Treatment for Aging-Related Diseases

(M1330-05-27) Geometry Study of Theophylline-Containing SLS Printed Pharmaceutical Tablets

(T1330-05-27) Utilizing Tiny-TIM to Assess the Food Effect on the Absorption of Orally Administered Drugs

(M1330-05-28) How a Sintering Enhancer Works as Multifunctional Ingredients for Selective Laser Sintering (SLS) 3D Printing of Pharmaceutical Dosage Forms

(T1330-10-56) Effect of Lipid Composition on the Atheroprotective Properties of HDL-Mimicking Micelles

(M1330-10-56) Impact of Nebulization on the Physicochemical Properties of Polymeric Nanoparticles for Pulmonary Drug Delivery Applications

(T1330-10-57) Female Sex Hormones Alter GHB Toxicokinetics

(M1430-05-27) An Oseltamivir Phosphate Case Study–Use of Mechanistic IVIVE Based PBPK Model for Assessment of Dissolution Safe Space in Adults and Extrapolation to Paediatric Subjects

(M1430-05-28) The Design and Development of GMC1 Analogues: Targeting the Regulation of Hormonal Receptors in Prostate Cancer Cells

(T1430-10-57) New Developments in the MolMeDB Database of Membrane Interactions of Small Molecules

(T1430-10-58) Tissue Distribution using Quantitative Whole Body Autoradiography (QWBA) of [¹⁴C]-Paclitaxel in Tumor Bearing Mice

(T1530-05-27) Co-delivery of siRNA and Chemotherapeutic Drug Using 2C5 Antibody Modified Dendrimer-Based Mixed Micelles for the Treatment of Multidrug Resistant Cancers

(M1530-10-57) Assessment of Kynurenic Acid as a Functional Biomarker of Organic Anion Transporter 1/3 (OAT1/3) in Cynomolgus Monkeys

(M1530-10-58) Gut Microbial Metabolites Regulate Bidirectional Transport and Intracellular Accumulation of Alzheimer’s disease Amyloid Beta Peptides at the Blood-Brain Barrier Endothelium

(W0930-05-27) Pharmacodynamic Assessments of Paclitaxel in Combination with Calcipotriol in Pancreatic Ductal Adenocarcinoma (PDAC)

(T0930-05-28) Antipsychotic Agent Pimavanserin, a Potential Therapy for Glioblastoma

(W0930-05-28) LC-MS/MS Method Development and Validation for Evaluation of Brain Pharmacokinetic Parameters of Metformin after an Intravenous Bolus Administration: Application in Ischemic Stroke

(T0930-05-29) Effect of Propofol on the In Vitro Model of the Blood-Brain Barrier Based on Induced Pluripotent Stem Cell-Derived Human Brain Microvascular Endothelial Cells

(M0930-05-29) Piperlongumine Reverses EGFR Resistance as an Adjuvant Treatment in Lung Cancer Cells

(T0930-10-58) Hazard Analysis of Amorphous Silica Nanoparticle via Acquired Immune System

(W0930-10-58) Modulating Host Response to Sepsis via Pure Anti-inflammatory Heparin-Like Compounds

(M0930-10-58) Modulation of the Activity of Histone Lysine Methylation Writers and Erasers in Leukemia Cells by a Curcumin Analog

(M0930-10-59) Implementing of Next-Generation Sequencing-Based Approach for Pharmacogenomics Profiling and Exploring Its Potential Clinical Utilities

(T0930-10-59) Interventional Treatment with an mPGES-1 Inhibitor Halts Further Growth of Abdominal Aortic Aneurysms in the Ang-II Mouse Model

(W0930-10-59) Intracellular Accumulation and Washout Kinetics of Aminoglycosides (AGS) in Multidrug-Resistant (MDR) Klebsiella pneumoniae

(W1030-05-28) Effects of B4GALNT1 Expression on Metastatic Phenotype and Response to Treatment in Osteosarcoma Cell Lines

(W1030-05-29) Cinnamaldehyde DNA Adducts are Mutagenic and Block Replication

(M1030-05-29) Computational Toxicity Prediction for Compounds of Unknown Toxicity using Bulk RNA-Seq: A Case of Liver Toxicity

(T1030-05-29) Radioprotective Effects of a Standardized Tocotrienol Rich Extract from Annato Seeds (Bixa orellana L.)

(M1030-05-30) Analysis of Amino Acid Content in Commercially Available Supplements

(W1030-10-58) Characterization of Selective CYP46A1 Inhibitors and Activators Across Compound Library Using a High-Throughput Screening Platform

(W1030-10-59) Replication Block and Mutagenicity of Aminofluorene-Guanine Adduct Inepigenetically Modified Sequence Contexts

(W1130-05-28) Polymeric Delivery with Dual Drug Payloads for Hepatocellular Carcinoma (HCC) Therapy

(T1130-05-28) The Inhibition of Proteolytic and ATPase Activities of the Proteasome by the BTK Inhibitor CGI-1746

(M1130-05-29) Development of Novel Macropinocytosis Inducers to Enhance Cellular Uptake of Small and Large Molecules

(T1130-05-29) Endogenous Blood-Brain Barrier Transporters are Critical Determinants of Neuroprotective Drug Efficacy in Ischemic Stroke

(W1130-05-29) Inactivation of Integrated Stress Response Pathway Sensitizes Triple-Negative Breast Cancer Cells to Proteasome Inhibitors

(M1130-10-58) Drug Repurposing: A Therapeutic Approach to Modulate Immune Microenvironment in Pancreatic Cancer

(T1130-10-58) Predictability of In Vitro Hepatocyte Induction Data in a PBPK Framework for CYP3A4 Induction Risk Assessment

(T1130-10-59) Simultaneously Inactivating Three or all Four Penicillin-Binding Proteins (PBPs) among PBP1a, 1b, 2 and 3 Synergistically Kills Acinetobacter baumannii (AB)

(M1130-10-59) Systems Biology Modeling of the Insulin Signaling Network in the Blood-Brain Barrier Endothelium Predicts Cerebrovascular Inflammation in Alzheimer’s disease

(T1230-05-29) Curcumin as a Repurposed Adjuvant to Overcome Antibiotic Resistance in Pseudomonas aeruginosa, Burkholderia cenocepacia and Burkholderia multivorans Clinical Isolates

(T1230-10-59) Discovery of Anti-LAG-3 Peptides for Cancer Immunotherapy

(M1230-10-59) Identifying Novel Synthetic Lethal Drug Targets to Overcome Chemotherapy Resistance in Triple Negative Breast Cancer by Genome-Wide CRISPR/Cas9 Screen Paralleled with Transcriptome RNAseq

(T1330-05-28) Prenatal E-Cigarette Use Disrupts Postnatal Blood-Brain Barrier (BBB) Integrity and Worsens Ischemic Stroke Outcomes- Implications on Brain Drug Delivery

(M1330-05-29) A Listeria-Based Vaccine Targeting Interferon-Stimulated Gene 15 for Renal Cell Carcinoma

(T1330-05-29) A Promising Protein Therapeutic Candidate for the Treatment of Cocaine Toxicity in the Presence of Alcohol

(T1330-10-58) Design and Development of Protease-Activated Chemically Self-Assembled Nanorings (Pro-CSANs) for Cancer Immunotherapy

(M1330-10-58) L-carnitine Challenge Test as an Indicator of Sex-Related Predisposition for Adverse Drug Reactions

(M1330-10-59) Determining the Efficacy and Toxicity Profile of Potential Oral Therapeutics Against SARS-CoV-2 in Mice

(T1330-10-59) Statins Constrict Resistance-Size Cerebral Arteries by Stimulating L-type Ca²⁺ Channels

(M1430-05-29) KY-054, a Novel 4-aryl Chromene Derivative, Enhances Osteoblast Differentiation of Mesenchymal Stem Cells and Shows Osteogenetic Effects in Ovariectomized Rats

(T1430-10-59) Development of a Broadly Active Influenza Intranasal Vaccine Adjuvanted with Self-Assembled Particles Comprised of Mastoparan-7 and CpG

(T1530-05-29) Nervonic Acid - A Potential Therapeutic Targeting Mitochondrial Dysfunction and Cellular Oxidative Stress

(M1530-10-59) Discovery of OJT009 as a Novel Inhibitor of Severe Acute Respiratory Syndrome Coronavirus 2

(M0930-04-22) Low Endotoxin Recovery (LER) Effect in Sample Solution of Monoclonal Antibody in Sodium Phosphate Dibasic and Citric Acid Anhydrous Constitution Buffer Analyzed with LAL Turbidimetric Kinetic Assay

(T1030-12-70) CSTD Force Testing Informs on Stopper Intrusion and the Force Users Must Overcome

(M1530-01-04) Formulation Design of WLBU2 Antimicrobial Peptide Dry Powder for Lung Infections

(T0930-01-01) Enhanced Conjugated Linoleic Acid Paclitaxel-Loaded Superparamagnetic Iron Oxide Nanoparticles for Anti-proliferative Activity in Non-Small-Cell Lung Carcinoma

(W0930-04-19) Cisplatin/Hyaluronan Complex: A Novel Loco-Regional Treatment in Tumors Over-Expressing CD44 Receptor

(M0930-07-38) Immune Cells Activating Biotin-Decorated PLGA Protein Carrier

(T0930-12-69) A Single Local Delivery of Paclitaxel and Nucleic Acids via an Immunoactive Polymer for Cancer Immunotherapy

(T0930-12-70) Imidazolium-Based Ionic Liquids in Orally Dissolving Films (ODFs) for Delivering Antihistamines

(M1030-01-01) HA Nanogel/Spike Protein Complex Induces One-Year Persistent Antibody Production

(T1030-03-13) Design and Optimization of Ciprofloxacin Hydrochloride Biodegradable 3D Printed Ocular Inserts: Full Factorial Design In Vitro and Ex Vivo Evaluations

(M1030-04-19) Influence of Varying Amount of an Inactive Ingredient on the Microstructure and Performance of Metronidazole Topical Gels

(W1030-04-20) Evaluation of In Vitro Performance Attributes of Imvexxy® (Estradiol) Vaginal Insert

(W1030-12-68) No Pain, Immunity Gain: Pain-Free Dissolving Microneedles as a Vaccine Strategy against Zika

(T1030-12-71) Enhancing Nucleic Acid Delivery to the Alcoholic Liver Using Polarized Macrophage-Derived Biomimetic Nanoparticles

(W1130-01-01) Hydrogel-Forming Microneedles in Combination with Risperidone/Hydroxypropyl-β-Cyclodextrin Inclusion Complexes for Enhanced Transdermal Delivery Potential for the Treatment of Schizophrenia

(M1130-01-06) A One-Two Punch Extracellular Vesicle Delivery System: Innate EV Mitochondria and EV/HSP27 Protect the Ischemic Brain Endothelium

(M1130-03-13) Impact of Host Physiological and Pathological Conditions on the Activity of Gut Microbial Beta-Glucuronidases toward Hydrolysis of Baicalin

(W1130-03-17) Enabling Oral Delivery of Exenatide by Designing Phospholipid Complexes for Self-nanoemulsifying Drug Delivery Systems

(M1130-07-37) Spleen-Targeting Delivery of Small Circular RNA Vaccines

(M1130-12-69) Release of Vaccine Nanoparticles from Hydrogels Intended for HIV Immunization

(T1230-03-13) Effect of α-tocopherol Conjugation on Polycation-Mediated siRNA Delivery to Orthotopic Pancreatic Tumors

(M1230-04-19) Dysphagia Prevalence and Pollution

(T1230-04-22) 3D-Printed Drug-Eluting Scaffolds for Mechanical Support and Regeneration: A Personalized Approach to Implant-associated Surgical Site Rehabilitation

(M1230-07-40) Ultra-deformable Nanocarrier of BRD4 PROTAC and Aurora Kinase B Inhibitor to Target “Undruggable” c-Myc in BRAF Inhibitor-Resistant Melanoma

(M1230-07-41) Effects of Lipidoid-Polymer Hybrid Nanoparticles on the Biophysical Function and Structure of Pulmonary Surfactant

(T1330-01-01) Long-Term Ocular Delivery of Griseofulvin for Therapy of Choroidal Neovascularization

(M1330-01-04) Injectability for High Concentration Monoclonal Antibody Formulations

(M1330-04-20) Tailoring the In Vitro Release of Reparixin-Loaded PLGA Microspheres

(T1430-01-02) Coarse-Grained Molecular Dynamics Simulations of ssDNA Loaded Adeno-Associated Virus

(T1430-03-13) A Novel Therapeutic Platform for Improved Glioblastoma Treatment

(T1530-01-01) Phosphatidylserine Targeting for Enhancing Immunochemotherapy of Cancer

(M1530-03-13) A Strategy to Deliver High Molecular Weight Hyaluronic Acid in Deep Lung: Investigating the Role of Non-immunogenic Surfactant

(M1530-12-68) Novel Selective PPARγ Agonist Locally Delivered with a Bioactive ROS-Scavenging Hydrogel for Periodontitis Treatment

(W1030-03-13) Inhalation Dry Powders of Monoclonal Antibodies Made by Thin-Film Freeze-Drying

(W1030-12-72) Nanostructured Lipid Carriers Enriched Gel for Enhancing Topical Delivery of Betamethasone Dipropionate in Treatment of Atopic Dermatitis

(W0930-04-21) Synthesis and Characterization of Functionalized Liposomes Encasing Angiotensin II Receptor shRNA for Management of Neurogenic Hypertension

(M0930-07-39) Developing an In Vitro System to Emulate the In Vivo Subcutaneous Environment and Predict the Fate of Drugs in Subcutaneous Delivery: Assessment of Biologics

(T1130-04-19) A Novel Self-Crosslinked Matrix Microneedle Patch for “Smart” Delivery of Insulin at Hyperglycemia

(W1130-07-39) A Solvent Free Thermo-Sensitive Gel Using Bioresorbable Polymers for Sustained Delivery of Biologic APIs

(W1130-07-41) Comparison of Centrifugation Method and Vacuum Method in Fabricating Microneedles

(T1330-03-13) Fabrication and In Vivo Evaluation of 3D Printed Biocompatible Dissolvable Microneedle Patch

(M1330-04-22) Controlling the Release of Copper from 3D Printed Calcium Phosphate Scaffolds for Bone Regeneration

(M1330-04-23) Reversible, Covalent DNA Condensation Approach via Chemical Linkers for Enhanced Gene Delivery

(W0930-01-02) Formulation Development of Enterically Protected Spray Dried Dispersions of Adrulipase

(W0930-03-14) Macrophage-Specific Nanoparticle Delivery of MicroRNAs to Mitigate Ventilator-Induced Lung Injury during Acute Respiratory Distress Syndrome (ARDS)

(M0930-04-19) Investigational Vaccine Induces Immune Correlates of Protection and Resistance to Infection against Neisseria gonorrhoeae in Mice

(T0930-04-22) Evaluating Immunization Efficacy of Self-administrable Subunit Microparticulate COVID-19 Vaccine Delivered by Nasal, Buccal, and Dermal Routes

(W0930-04-22) Subunit Particulate Vaccine Delivered by Microneedles Elicits Th-1 Skewed Immune Responses Protecting against RSV

(W0930-12-70) Novel Sidekick in Vaccine Formulations: Microparticle Autoinducer-1

(M1030-01-02) Biomimetic SARS-CoV-2 Spike Protein Nanoparticles as Viral Inhibitors against COVID-19

(W1030-07-37) Production and Optimization of Nanosac as a Soft Nanocarrier for siRNA Delivery to Solid Tumors

(T1130-03-15) Development and In Vitro Characterization of STAT6 siRNA Loaded PEGylated Gelatin Nanocarriers as an Anti-Asthmatic Therapy

(W1130-04-19) A Novel Solid the Lipid Nanoparticles Formulation with Anti-inflammatory Properties for RNA Delivery

(W1230-01-01) Trafficking of Acetalated Dextran Microparticles after Subcutaneous Injection

(M1230-01-02) Ionizable Lipid Nanoparticles for Precise Intracellular Delivery of CpG DNA Adjuvant

(T1230-01-02) Stabilization of Recombinant DNA in a Polymer Based Film Matrix

(W1230-07-37) Understanding the Effects of Varying Mannitol Concentrations on Inhalable Protein Formulations

(T1230-07-37) Using Enzymes to Accelerate PS80 Degradation and Elucidate Mechanistic Impacts of PS80 Degradation on Biologics Drug Product Quality

(T1230-07-42) Characterizing Potency of Model AAVs Using Imaging Flow Cytometry

(M1230-12-67) Spray-Dried Inhaled Solid Dispersion of Amodiaquine for Respiratory Disorders

(T1230-12-67) Stabilize and Formulate Yeast-Based Immunobiologics by Lyophilization for Oral Delivery

(T1330-03-17) Formulating Adenosine for Localized Delivery

(T1330-04-19) Developability Assessment as an Early De-risking Tool for Biopharmaceuticals: Case Study with Fusion-Proteins

(M1330-04-21) Preparation and Characterization of Poorly Soluble Protein (MET 0226) Liposomal Nanoparticle by High Press Homogenizer

(M1330-07-37) Preparation of Polymeric Albumin Nanoparticles by a One-Step Spray Drying Process

(T1330-07-40) An Oral Lipid Nanocomplex Incorporating BRD4 PROTAC and Vemurafenib Overcomes BRAF Inhibitor Resistance in Malignant Melanoma In Vivo

(T1330-12-67) Fourier Transform Infrared Spectroscopy (FT-IR) of Lyophilized RNA

(T1430-07-37) NanoFabTx™: A Step-by-Step Quick Screening Platform for Liposomal Drug Delivery Systems

(T1530-04-19) Hydrophobic Ion Pair for the Oral Delivery of Leucine-Enkephalin

(T1530-07-37) Attenuating Neuroinflammation and Promoting Neurogenesis through Co-delivery of Curcumin and Brain Derived Neurotrophic Factor (BDNF) for the Management of Alzheimer’s disease

(M1530-07-37) Bioengineered Smart Microcapsules Containing Natural Killer Cells for the Treatment of Pediatric Cancers

(T1530-07-41) Comparison of Trehalose and Sucrose in Preserving and Stabilizing Lyophilized Therapeutic Proteins

(T1530-12-67) Remote Loading of Auto-Antigens in PLGA Nanoparticles for the Treatment of Autoimmune Diseases

(T1030-04-24) Intracellular Delivery of Plasmid DNA Using TPGS Formulated Lipid Nanoparticles

(M1130-12-72) Inulin-Based Dual-Function Polymer for Enhanced Delivery of Nucleic Acids to the Kidney

(M1230-07-42) Investigating Protein-Excipient Interactions of a Multivalent V_HH Therapeutic Protein using NMR Spectroscopy

(M1330-04-24) Dual Immunization Against COVID-19 and Influenza Using Fast-Dissolving Buccal Films

(M1330-12-72) Leveraging Developability Risk Assessment Insights to Identify Key Structural Liabilities and Inform Formulation Strategy for Novel Biologics Modalities

(M0930-01-01) A Retrospective Analysis of Pharmacokinetic Variability between Fasting and Fasting-Sprinkle Bioequivalence Studies of Generic Modified-Release Drug Products: A Case Study on Esomeprazole Magnesium

(T0930-07-38) Dissolution Bioequivalence Safe Space Assessment of Molnupiravir and NHC Using Physiologically Based Biopharmaceutics Modeling

(W1030-03-14) Development of a Low-Volume In Vitro Dissolution Method for Assessing Variability in Fine Particle Doses of Dry Powder Inhalers

(T1030-03-14) Investigation of Phenoxyethanol Permeation Using the Skin Parallel Artificial Membrane Permeability Assay (PAMPA) Membrane and Mammalian Skin: Correlation and Rank Order

(M1030-03-15) Predicting the Pharmacokinetics of Amorphous Dispersions Using Canine PBPK Models

(M1030-04-20) Amorphous Solid Dispersions for Enhancement of Equilibrium Aqueous Solubility of Sulfamethoxazole

(T1130-01-02) In Vitro Digestion-Diffusion Model for Predicting In Vivo Performance of Lipid-Based Formulations

(W1130-01-02) Study of Etamsylate Release Kinetics from Controlled Release Matrix Tablets Using the Buffer Transition In Vitro Dissolution Method

(M1130-01-05) Evaluating Influence of Critical Quality Attributes of Metronidazole Topical Gel on Bioequivalence Using the Dermal Virtual Bioequivalence (VBE) Module in Simcyp Simulator

(M1130-12-68) Hydroalcoholic Media Effects on Ibuprofen Release from Low Acyl Gellan Gum

(T1230-03-14) Regional Bile Salt and Lipid Concentrations in the Rat Small Intestine: A Comparison between the Lumen and the Mucus Layer

(M1230-04-20) Development of an In Vitro Release Method for Mechlorethamine Hydrochloride Topical Gel

(T1330-01-02) Application of Bottom-Up Absorption Model for Biopharmaceutics Risk Assessment of Preclinical Candidate

(M1330-03-14) Apparent Danazol and Ketoconazole Solubility in the Upper Gastrointestinal Lumen after Administration of a Standard High-Calorie, High-Fat Meal and Its Estimation Using Biorelevant Media

(M1330-12-68) Establishing In Vitro-In Vivo Correlation of Amorphous Solid Dispersions

(M1430-01-02) Impact of Changes in Ophthalmic Emulsion Globule Size Distribution and Viscosity on Tear Film Thickness and Menisci Characteristics

(T1430-03-14) In Vitro Permeation Studies Combined with Microdialysis Sampling Allow Mechanistic Insights into the Dynamic Dissolution-/ Bioconversion-/ Permeation-Behavior of the Prodrug Fosamprenavir

(T1530-01-02) Biopharmaceutical Modeling of Food Effect – Exploring a Role for Dietary Fat

(M1530-03-14) A New Modelling Framework for pH-Sensitive Solid Dispersions Release and Dissolution

(M0930-01-03) Near-Infrared Light Triggered In Situ Cu(DDC)₂ Complex Formation and Reactive Oxygen Species Amplification Cascade for Cancer Therapy

(W0930-01-03) Physically- and Chemically-Enhanced Transdermal Delivery of Linagliptin

(M0930-03-13) Development and Characterization of Primaquine and Chloroquine Solid Dispersion Loaded Dissolving Microneedles for the Improved Treatment of Malaria

(T0930-03-13) Preparation and Evaluation of 3D Printed Capsaicin-Loaded Rod-Shaped Implants for Treating Obesity and Hyperlipidemia

(T0930-03-14) Role of Excipients on Drug Release from Long-Acting Intrauterine Systems

(T0930-03-17) Controlled Delivery of Emtricitabine and Bictegravir from Nanoparticles for the Management of HIV Associated Neurocognitive Disorders (HAND): Effect of Methods of Preparation and Surfactants

(W0930-03-17) Functionalized PLGA Nanoparticles Encapsulating Emtricitabine and Bictegravir for Delivery Across the Blood Brain Barrier for the Management of HIV Associated Neurocognitive Disorders (HAND)

(M0930-04-20) Comparative Study of Capsule-Based DPIs for Drug Detachment from Carrier Particles in Interactive Blends

(W0930-04-23) Development and Evaluation of a Drug-in-Adhesive Transdermal Delivery System for Delivery of Olanzapine for Treatment of Schizophrenia and Bipolar Disorder

(T0930-04-23) Put a Ring on It: 2-Hydroxypropyl-β-cyclodextrin-Complex-Cabotegravir Sodium with Hydrogel-Forming Microarray Patches for Minimally Invasive HIV- Pre-exposure Prophylaxis

(W0930-07-37) Development of MMP2-Sensitive Carbon Nanotubes for Tumor-Targeted Drug Delivery

(W0930-07-38) Sprayed Multi-Adsorbed Droplet Reposing Technology (SMART) for Fabrication of a Protein Drug Delivery System

(W0930-07-39) Development of Biodegradable Injectable In Situ Forming Implants for Controlled Release of Cannabinoids: In Ovo Assessment

(M0930-07-40) Light Activatable Prodrug Strategy to Treat Non-muscle Invasive Bladder Cancer

(M0930-12-67) Liposome as a Carrier for Delivery of Cannabidiol and pAPOE2 for the Management of Alzheimer's Disease

(W0930-12-67) Release Mechanism and Performance Prediction of a Multi-Block Copolymer-Based Long-Acting Reversible Contraceptive (LARC) Implant

(M0930-12-68) Ethyl Cellulose Coated Polymeric Microneedles for Sampling of Drugs and Biomarkers from the Tissues

(T0930-12-68) Eudragit Coated Polymeric Microneedles for Intradermal Controlled Delivery of Drugs

(W0930-12-69) A Single Dose of Nanoparticle Provides 6 Months Efficacy for Preventing Rat Corneal Allograft Rejection

(M0930-12-69) Phyto-Nano-Silver containing Lipo-Carriers for the Treatment of Thermal Burn Wounds

(W0930-12-71) 3D Printed Implants for the Treatment of Periprosthetic Joint Infections

(T0930-12-71) Preparation and Characterization of Apixaban with Anti-crystallizer PLGA Microsphere Using Prilling by Vibrating Microfluidic Device

(W1030-01-01) Formulation Development and In Vitro-Ex Vivo Characterization of Hot-Melt Extruded Ciprofloxacin Hydrochloride Ocular Inserts for Topical Ocular Applications

(W1030-01-02) Oral Nano-curcumin Alone or In Combination with Insulin Alleviates Diabetic Neuropathy in Rats

(M1030-01-03) In Vitro Permeability Comparison Study: Skin versus Two Biomimetic Barrier Permeapad™ and SCM

(W1030-01-03) Pharmacokinetic and Pharmacodynamic Study of Long-Acting Apixaban Microsphere Injection

(T1030-01-04) Microparticles-Loaded Dissolving Microarray Patches for the Depot Intradermal Long-Acting Delivery of Atorvastatin

(M1030-03-14) Hot-Melt Extrusion as a Novel Technique to Develop Polymeric Micelles for Drug Delivery

(T1030-04-21) Lyotropic Liquid Crystal Drug Delivery System: Cubosome Encapsulate Cromolyn Sodium for Oral Delivery

(M1030-04-21) Practical Preparation of Reproducible PLGA Nanoparticle for Intravenous Drug Administration

(T1030-04-22) Codelivery of Hydrophobic and Hydrophilic Drugs with PLGA-Tipped Hydrogel-Forming Hybrid Microneedle Patches

(W1030-04-22) Hispolon Cyclodextrin Complexes and Cyclodextrins-in-Liposomes for Enhanced In Vitro Anticancer Activity against Melanoma

(W1030-04-23) ELC-Cu Nanoparticles Induce Cell Death by Mediating Mitochondria Oxidative Stress and Trigger an Innate Immune Response for Cancer Therapy

(T1030-07-38) Nanovesicle Delivery Systems Containing Doxorubicin Hydrochloride and Paclitaxel for Breast Cancer Treatment

(W1030-07-38) Preparation and Pharmacokinetic Evaluation of Long-Acting Injectable Nanocrystalline Suspension of Montelukast

(T1030-07-39) Development, Characterization and Stability Studies of Amphotericin B and Nonadecanoic Acid loaded Nanostructured Lipid Carriers for Fungal Keratitis

(M1030-07-40) Fabrication of Drug-Loaded Polymeric Micelles Using Homo-PEG as Both the Solvent and the Lyoprotectant for Freeze-Drying

(M1030-12-67) Comparative Evaluation of In Vitro Release Profile of Hydrogen Sulfide from Its Donors

(T1030-12-67) Multiphysics Simulations and Pharmacokinetic Modeling of Long-Acting Injectable Delivery Systems

(W1030-12-67) Optimization of the In Vitro Skin Permeation of Resveratrol from Microemulsions

(M1030-12-68) Perfluorocarbon Nanoemulsions as Artificial Oxygen Carriers–Initial Proof-of-Concept to In Vitro Tissue Culture Efficacy

(M1030-12-69) Terbinafine and Ciclopirox Ungual Delivery from New Vehicles across Porated and Non-porated Human Nails

(W1130-01-03) Study of Physiological Buffering Effects on Ezetimibe Supersaturation Using Hydroxypropyl Cellulose as Precipitation Inhibitor

(M1130-01-04) Hydrogel-Forming Microarray Patches Combined with Poly(ethylene)glycol Reservoirs for the Long-Acting Intradermal Deposition of a Poorly-Soluble Drug

(W1130-03-13) Assessing the Impact of Surface Energy of Probe on Adhesive Properties Using Novel 3D Printing Approach

(W1130-03-15) Development of Bupivacaine Hydrochloride Mucoadhesive In Situ Forming Gels for Oral Mucositis

(M1130-03-15) Novel Lipid Nanoparticles for Potential mRNA Delivery Vaccine Applications

(W1130-03-16) Development of Enhanced the Physicochemical Properties, Solubility, and Oral Bioavailability of Rivaroxaban-Loaded Solid Self-nanoemulsifying Drug Delivery Systems

(M1130-04-19) Stability and Optimization Study of Cisplatin/Hyaluronan Film for Loco-Regional Drug Delivery in Cancer

(T1130-04-20) An Improvement Grade of Hypromellose for Industrial Scale CR Tablet Manufacturing

(W1130-04-21) Fluorescently Labeled P407 Enters Micropores Generated Using Microneedles

(M1130-04-21) Penetratin and Transferrin Functionalized Liposomes Can Deliver Losartan Potassium to the Brain of Wistar Kyoto Rats

(M1130-07-38) Evaluation of Surface-Modified PLGA Nanoparticles to Enhance Absorption of Sorafenib for the Treatment of Liver Cancer

(M1130-07-39) Nanodisc Delivery of Liver X Receptor Agonist for the Treatment of Diabetic Nephropathy

(W1130-07-40) Effect of Receptor Medium on Skin Permeability during In Vitro Skin Permeation Test (IVPT) Experiment

(T1130-07-40) Enhancement of Transdermal Permeation of Cannabinoids and Their Pharmacodynamic Evaluation in Rats

(T1130-07-41) Cyclodextrin Enabled Formulations of Unstable and Poorly Soluble Compounds for Topical Ophthalmic Delivery

(W1130-12-68) High Drug Loading Sustained-Release Metformin HCl Tablets: Hydroxypropyl Methylcellulose (HPMC) Based Semi-solid Extrusion 3D Printing

(T1130-12-68) Thermosensitive Lactobacillus brevis-Loaded Composite Double-Layered Dressing with Improved Mechanical Properties and Excellent Wound Recovery

(T1130-12-69) Multifunctional Terpolymeric Blood-Brain Barrier Penetrating MnO₂-Loaded Nanoparticles for Tumor Microenvironment Modulation and Radiation Sensitization of Glioblastoma

(W1130-12-69) Novel Electrospun Nanofiber Buccal Films for Treating Opioid Use Disorder

(M1130-12-70) Development and Evaluation of Transdermal Delivery System of Tranylcypromine for the Treatment of Depression

(W1230-01-02) Matrix Metalloproteinase-Responsive Hydrogels for the Treatment of Inflammatory Skin Diseases

(M1230-01-03) Characterization of the Enteric Performance of an Innovative Functional Capsule

(T1230-03-15) Colon Targeted Ibrutinib Amorphous Solid Dispersions for the Treatment of Colorectal Cancer

(M1230-03-15) Vacuum Compression Molding as a Novel Technique for the Fabrication of Polymeric Microneedles

(M1230-03-16) Nose to Brain Delivery of Donepezil after the Administration of HPMC-Me-β-CD-PEG400 Based Nasal Films in C57BL/6J Mice

(M1230-03-17) Chemosensitization of Liver Cancer Cells Using Synergistic Inhibitor Combination Co-loaded in Docosahexaenoic Acid Based Self-Nanoemulsifying System

(M1230-03-18) Using Targeted Lipid Nanoparticles to Deliver Chemotherapy to Pancreatic Cancer

(T1230-04-20) Theranostics Peptide Functionalized Graphene Oxide Quantum Dots for Targeted Detection and Treatment of Colorectal Cancer

(T1230-04-23) First-in-Class 3D Printing Technology to Fabricate 6-Thioguanine-Loaded Microparticles for Potential COVID-19 Treatment

(M1230-07-37) Novel Composite Collagen-Hyaluronic Acid-Sodium Alginate Based Scaffolds Crosslinked with Calcium Chloride for Potential Chronic Wound Healing Applications

(T1230-07-38) Polymeric Chloroquine as an Oral Chemopreventive Agent for Colorectal Cancer

(W1230-07-38) Transdermal Delivery of Diclofenac Base: Effect of Silicone and Acrylic Pressure Sensitive Adhesive Blends on Drug Delivery and Adhesive Performance

(W1230-07-39) Nanocarriers’ Repartitioning of Drugs within the Blood Compartment as a Mechanism of Improving Pharmacokinetics and Efficacy

(T1230-12-68) Formulation of PEGylated Liposomes to Reduce Vancomycin Induced Kidney Injury: A Rat Study

(M1230-12-69) Cytotoxicity, Safety and Mammary Tissue Retention of Nanostructured Lipid Carriers Co-encapsulating Paclitaxel and Tributyrin as a Novel Approach for Local Breast Cancer Treatment

(M1330-01-02) Preparation and Evaluation of Celecoxib Nanosuspension for Enhancing Its Solubility

(T1330-01-03) Lipid Conjugation to Brush PEG Polymer Delivery Systems Enables Hitchhiking on Lipid Trafficking Pathways to Manipulate Plasma Half-Life, Lymph Uptake and Biodistribution

(M1330-03-15) Control of Drug Release Kinetics from Hot-Melt Extruded Drug/Polycaprolactone Matrices

(T1330-03-15) Exploring Paclitaxel Loaded Adenosine Conjugated PEGylated PLGA Nanoparticles for Targeting Triple-Negative Breast Cancer

(T1330-04-20) Hydrodynamic Robustness of New Hydroxypropyl Cellulose Grade for Modified Release Matrix Systems

(T1330-04-21) Lipid Core Nanocapsules for Drug Delivery of Antimicrobials

(M1330-07-38) Comparison of Hydrangea macrophylla Flower Extract on the Permeability and Skin Whitening of Ginsenoside Rh1 Based on Cream Formulation

(M1330-07-39) Photochemical Reaction Mechanism and Kinetics of Nitric Oxide (NO) Release from Solid S-nitrosothiol

(T1330-12-68) Folic Acid Conjugated Lipid Nanoparticles containing CORM-2 for Inflammation-Targeted Carbon Monoxide Delivery

(T1430-01-03) Coaxial Electrospun Fabric as a Drug Delivery Platform for Mafenide Acetate and Polyhexanide to Combat Burn Wound-Associated Infection

(M1430-01-03) Topical/Transdermal Strategies for Decontamination of Chemical Warfare Agents and Delivery of Antidotes

(T1430-01-05) Qualitative and Quantitative Analysis of Drug Diffusion, Into and Across Dermaplaned Skin

(M1430-03-16) Palmitoyl Carnitine-Anchored Nanoliposomes for Pancreatic Cancer and Neovasculature-Specific Delivery of Gemcitabine Elaidate

(M1430-03-17) Design and Development of Folate Decorated Nanoemulsions as the New Pain Nanomedicines

(M1430-04-19) Facile Dual-Drug Delivery System Based on In Situ Gelling Nanosuspension Formulation of Water-Insoluble Cyclic Peptides

(M1430-04-20) Development of Novel Topical Formulations of 5-fluorouracil

(T1430-04-20) Formulation and Ex Vivo Permeability of Diphenhydramine Orally Dissolving Films (ODFs) for Buccal Drug Delivery

(T1430-04-21) In Vitro Evaluation of Foamable Diclofenac Sodium Loaded Topical Microemulsion

(M1430-07-38) Capmul-Based Formulations for Topical Delivery of Prodrugs Derived from Methotrexate and 5-Aminolevulinic Acid

(T1430-07-38) Different Pharmacokinetics and Local Inflammation between Injectable Aqueous Drug Suspension and Oil Suspension

(T1430-07-39) Modifying Drug Release from Microparticles Prepared by Spray Drying Using a 3-Fluid Nozzle

(M1430-12-67) Assessing the Effect of Barrier Integrity on Topical and Transdermal Delivery of Diclofenac Sodium Using Physical Enhancement Techniques

(T1430-12-67) Development of Topical Foam Formulation for Decontamination Post Exposure to Lewisite and Extended Antidote Delivery upon Reapplication

(M1530-01-01) Modification of Paclitaxel Nanocrystals by Hydroxypropyl-Beta-Cyclodextrin to Improve Their Release Characteristics, Safety, and Efficacy

(T1530-01-03) Feeling the Pressure: Polymorphism, Particle Size and Morphology Control Through Nanoparticle Crystallization Using Controlled Expansion of Supercritical Solutions

(M1530-01-05) Rapidly Dissolving Polymeric Microneedle Skin Patch of Naloxone for Opioid Overdose Treatment

(T1530-03-14) LHRH-Targeted Nano-repurposed Drug Carriers for Triple Negative Breast Cancer Treatment

(M1530-03-15) Drug-Loaded Hydralese™ Poly(Glycerol Sebacate) Urethane Elastomers as Intra-vitreal Microdevices for Ocular Drug Delivery Applications

(T1530-03-17) Imaging Analysis of Corneal Fluorescein Permeation Kinetics

(T1530-04-20) Oral Drug Delivery Strategy Using Bile Acid Decorated Nanoparticles

(M1530-04-20) Reducing the Pro-Inflammatory and Cytotoxic Side Effects of siRNA- Solid Lipid Nanoparticles by Optimizing Cationic Lipid; DOTAP

(M1530-04-21) Assessing In Situ Forming Implants Using Real-Time Imaging

(T1530-04-21) Dose Dependency Effect on the Skin Permeation of Polar and Non-Polar Compounds

(M1530-04-22) Co-formulating Inhalable Powders of Nintedanib, Pirfenidone and Mycophenolic Acid by Thin-Film Freezing Technology

(M1530-07-38) Design and Development of Rifampicin Loaded  PLGA Nanoparticles for the Prevention of Prosthetic Infections

(M1530-07-39) Formulation and Characterization of Gatifloxacin Sesquihydrate Nanostructured Lipid Carriers for Bacterial Conjunctivitis

(T1530-12-68) Preparation and Evaluation of Sorafenib Nanosuspensions Using High Pressure Homogenization Technique for Improved Oral Bioavailability

(T1530-12-69) Shear-Thinning Injectable Hyaluronic Acid Hydrogels for Diabetic Wound Healing

(M1530-12-71) Nanoparticle-Based Drug Delivery Approach Increased the Bioavailability and Efficacy of the ART Therapy in Vitro

(M1130-04-23) Novel Formulation for Simultaneous Decontamination of Chemical Warfare and Delivery of Antidotes for Attenuating Cutaneous Damage Caused by Arsenicals

(T1430-01-06) Fabrication of pH-Responsive Acetalated Dextran Nanoparticles Using Flash Nanoprecipitation for Intracellular Delivery of Payloads

(T0930-07-39) Developing an In Vitro System to Emulate the In Vivo Subcutaneous Environment and Predict the Fate of Drugs in Subcutaneous Delivery: Assessment of Small Molecule Drugs

(M1030-01-04) How Do Extracellular Vesicles Enter Recipient Brain Endothelial Cells?

(T1130-01-04) Expandable Single-Component Gastroretention Devices: Shape Optimization and Proof of Concept for Extended Gastric Residency and Drug Release In Vivo

(W1130-01-04) Identifying the Operating Space and Repeatability of a Novel Filament Free FDM Printer

(M1130-03-16) Printability of Pharmaceutical Fused Deposition Modeling (FDM) Feedstock Material: Mechanical Characterization of FDM Filaments and the FDM 3D Printing Process

(M1230-01-04) Development of 3D-Printed Gastro-Retentive Sustained Release Mini Device Using Ingestible Compounds

(T1330-03-16) Design of a Personalized Nasal Device (Matrix-Piston Device, MPD) for Nose-to-Brain Delivery: A 3D-Printing Application

(M1430-01-04) Effect of Plasticizer on the Fabrication and Properties of Hot-Melt Extruded Filaments and Fused Deposition Modelling (FDM) 3D Printed Tablets

(T1430-04-19) Characterization of Aerosolized Droplets Using a 3D Printed Device for Small Animal Nose-to-Brain Drug Administration

(T1430-04-22) Developing an Inhaled Nano-Emulsion for Repurposing an Herbal Drug for Non-small Cell Lung Cancer

(M1430-12-69) Development of Multilayer 3D DLP Printed Tablet in One Step Using Automated Rotary Platform

(T0930-01-02) A Physical Picture for the Dissolution Process of Copovidone ASDs

(M0930-01-04) Role of Propylene Glycol in the Transdermal Permeation of Clobetasol

(W0930-01-04) Spray Drying Versus Coprecipitation for Processing Amorphous Solid Dispersions

(W0930-01-05) Impact of Spray-Dried Dispersion Formulation and Composition of Physiological Fluid on Micellar and Colloidal Speciation

(M0930-01-05) Investigating Telmisartan Loaded Oral Microparticles Prepared by an Emulsion-Based Approach

(M0930-01-06) Determination of Time-Temperature-Transformation Curve for Sulfonyl Urea Analogues in the Presence of a Crystallization Inhibitor using Simultaneous XRD-DSC

(W0930-03-13) Impact of Film-Coating Excipient Selection on Tablet Performance and Stability

(M0930-03-14) Enhancement of Raloxifene Hydrochloride Bioavailability by Solubility Improvement and Metabolism Inhibition Employing Hot-Melt Extrusion

(T0930-03-15) How to Ensure a Successful Tablet Coating Formulation Development by Using Polyvinyl Alcohol in Combination with Calcium Carbonate to Provide an Alternative to Titanium Dioxide

(M0930-03-15) Novel Fast Track Method for Stability Studies of Amorphous Solid Dispersions via Powder X-ray Diffraction and Vacuum Compression Molding

(W0930-03-15) Understanding the Stabilization Mechanism of Polyvinyl Alcohols (Parteck® MXP) in ASDs by Structure-Related Properties and PC-SAFT Modeling

(W0930-03-16) Comparison of Dialysis and USP-4 Methods to Differentiate Drug Release from Mesalamine Rectal Suppositories

(T0930-03-16) Investigating the Synergistic Effect of Polymethacrylates and HPC as Polymeric Carrier for Drug Solubility Enhancement

(M0930-03-17) Study of High Dose Vitamin C (1000 mg) ER Hydrophilic Matrix Tablet using METHOCEL™ as the Rate Controlling Polymer

(W0930-04-20) Comparative Investigation of Albendazole Amorphous Solid Dispersion Prepared by Supercritical Fluid Technology and Hot Melt Extrusion

(T0930-04-20) Hansen Solubility Parameters Estimates of Amorphous Dispersion Behavior Are Accurate in Some Cases but Often Inconclusive

(M0930-04-21) Dual Functionality of Bile Acid: Physical Stabilization of Drugs in the Amorphous State and Solubility Enhancement in Solution

(T0930-04-21) Role of Drug–Polymer Interactions and Polymer Concentration on Critical Cooling Rate during Hot-Melt Extrusion of Amorphous Solid Dispersions

(W0930-07-40) In Vivo Evaluation of Bexarotene Oral Microparticles in Beagle Dogs

(T0930-07-40) Tunable Drug Release from Fused Deposition Modelling (FDM) 3D Printed Tablets Fabricated Using a Novel Extrudable Polymer

(T0930-07-41) Development of Scalable and Inhaled Nintedanib-Loaded Polymeric Nanoparticles for Localized Therapy of Idiopathic Pulmonary Fibrosis

(W0930-07-41) Nanosuspension Organic Phase Instead of Solution Water Phase: A New Approach to Loading Hydrophilic Trivalent Arsenic Salt with Hydrophobic Polymer

(M0930-07-41) Surface-Modified Inhalable Microparticle-Encapsulated Triterpenoid for Enhanced Efficacy in Malignant Mesothelioma

(T0930-12-67) Glimepiride Releases from Laboratory Compounded and Two Commercial Tablets Using a Proposed Three Stage In Vitro Dissolution Study

(W0930-12-68) Development and In Vivo Testing of an Enteric Oral Dosage Form of an Amorphous Solid Dispersion in Beagle Dogs that Generates Amorphous Nanoparticles during Dissolution

(M0930-12-70) Amorphous Lactose Solid Dispersion Co-Spray Dried with Magnesium Stearate as a Novel Lactose Carrier

(T1030-01-02) N-nitrosodimethylamine and Dissolution Assessment of Commercial Metformin Products in In-Use Stability Testing

(T1030-01-03) Development and Characterization of Multi-layer Self-Nanoemulsifying Pellets Using Fluid Bed Coating Technique to Enhance the Dissolution and Stability of Ramipril

(M1030-01-05) Intrinsic Dissolution of New Pharmaceutical Film Coating Systems

(W1030-01-05) On Dose Authentication Using Molecular Taggants Applied in a Clear Film Coat

(M1030-01-06) Development of a Child-Friendly Antibiotic Packed Multiparticulate Oral Sprinkle Formulation for Tuberculosis Pharmacotherapy

(M1030-03-13) Employing Hot-Melt Extrusion Technology to Enhance the Solubility of Cannabidiol (CBD)

(W1030-03-16) Comparative Analysis of ‘All-in-One’ Co-processed Excipient Versus Its Proportional Individual Blend in the Production of Vardenafil HCl Tablets via Direction Compression

(M1030-03-16) Investigation of Thermoelastic Properties of a Novel Extrudable Polymer Poly-2-ethyl-tetra-oxazoline (PETOX) for the Development of Amorphous Solid Dispersions by Hot Melt Extrusion

(T1030-03-16) Research of Powder Properties of Microcrystalline Cellulose Grades Desirable for Direct Continuous Compression System

(W1030-03-17) Novel Screening Tool for Predicting Mechanical Properties of Filaments Processed via Hot Melt Extrusion

(M1030-03-17) Spray Drying of Amorphous Solid Dispersions (ASDs): Small Scale Screening of Batches containing Less than 50 mg API

(T1030-03-18) Drug and Colloidal Characteristics Impact the Unstirred Water Layer Thickness

(W1030-03-18) Palatable Tamoxifen Rodent Diet: An Innovative Administration Method in Mice to Achieve Inducible Cre Recombinase

(T1030-04-19) Formulation Development of Dietary Supplements and Stability Prediction Using Accelerated Stability Assessment Program

(W1030-04-19) Inhalable Dry Powder Formulation of PLGA Microparticles Loaded with Clofazimine for Treatment of Tuberculosis

(W1030-04-21) Design of Amorphous Solid Dispersions for the Synchronized Release of Two Drugs

(M1030-04-22) Control of Recrystallization in Tablets Containing Amorphous Solid Dispersion

(M1030-04-23) Use of Mega Beads in Designing a Single Unit Biphasic Dosage Form

(M1030-04-24) Sustained Release Orally Disintegrating Tablets (ODTs) Comprising Coated Microparticles to Improve Acceptability in Patients with Dysphagia

(M1030-07-37) Taste Optimization in Oral Dosage Forms: A Sensory Panel Study with the Focus on High-Intensity Sweeteners

(M1030-07-38) Development of Lipid Formulation for Oral Delivery of Proteins and Peptides with Poor Permeability

(M1030-07-39) Days or Centuries? Predicting the Shelf-Life of ASDs

(T1030-07-40) Delivering Smarter Medicines with On-Dose Microtaggants and Smartphone Technology

(W1030-07-40) Screening Primary Parameters Affecting Formulation of Hydrogen Sulfide Donors-Loaded Microparticles using Quality-by-Design (QbD) Approach

(M1030-07-41) Biorelevant Dissolution Method Considerations for the Appropriate Evaluation of Amorphous Solid Dispersions: Are Two Stages Necessary?

(W1030-07-41) Enhanced Oral Bioavailability of Resveratrol Using Various Formulation Strategies

(T1030-07-41) Understanding the Role of Phase Separation in Dissolution of Amorphous Solid Dispersions (ASDs)

(T1030-07-42) Fabrication of Controlled Release Dosages via Selective Laser Sintering Three-Dimensional (3D) Printing Technology

(W1030-07-42) Long-Term Stability Studies of Extemporaneously Compounded Amiloride Nasal Spray

(T1030-12-68) Applications of Deep Learning to Predict Aerosol Performance of Dry Powders for Inhalation

(T1030-12-69) Development of Amorphous Solid Dispersion of Aprepitant Using Sucrose Acetate iso butyrate for Dissolution and Bioavailability Enhancement

(W1030-12-69) Optimization of Amorphization Kinetics during Hot Melt Extrusion by Particle Engineering

(W1030-12-70) A Rheological Approach for Determining Miscibility of Amorphous Solid Dispersions

(M1030-12-70) Solubility Enhancement of BCS Class IV Drug Acyclovir Using Hot Melt Extrusion

(W1030-12-71) Application of Sodium Alginate as Raft-Forming Agent in Anti-reflux Chewable Tablets

(M1030-12-71) Equilibrium Solubility and Solute-Solvent Interactions of Four Drugs in Mono-Solvents

(M1030-12-72) Enhancement of Crystal Nucleation at a Liquid/Vapor Interface

(T1030-12-72) Pharmaceutical Formulation and In Vitro Analyses of a Paediatric Fixed-Dose Combination Antimycobacterial Reconstitutable Oral Suspension

(M1130-01-02) Impact of Granulation Solvent on Release Performance of Dual Matrix Extended-Release Tablets of Highly Water-Soluble Drugs Formulated Using Compritol^®888ATO and Methocel^® as Release Retarding Agents

(M1130-01-03) Using Design of Experiments (DoE) in Validation of Camo-peg NL Formulation

(T1130-01-05) Recent Advances in ASD Formulations: HIPROS and Dispersome

(W1130-01-06) Amorphous Chemical Stability of an Oral Tablet Using Moisture-Modified Arrhenius Modeling

(T1130-01-06) Eliminating Upper Gastrointestinal Irritation of a Novel Therapeutic (SCTL-007) by Developing Modified Release Matrix Tablets Utilizing HPMC Polymers

(T1130-03-13) Mechanical Properties of Reinforced Polyvinyl Alcohol Cryogels

(W1130-03-14) Development and Evaluation of a Label Friendly Film Coating System Containing Naturally Derived Opacifier

(T1130-03-16) Thermodynamic Phase Diagrams for Predicting Drug-Polymer Miscibility of High Melting Point Drugs with Poly-2-ethyl-tetra-oxazoline for Development of Amorphous Solid Dispersions

(T1130-03-17) Kinetic Barriers to Disproportionation of Salts of Weakly Basic Drugs

(M1130-03-18) Developing In Vitro Lipolysis Model for Real-Time Analysis of Drug Concentrations during Digestion of Lipid-Based Formulations

(T1130-03-18) Impact of Coating Process Parameters on Drug Layering of Sitagliptin over Metformin HCl ER Tablets

(M1130-04-22) Anticancer Activity and Pulmonary Delivery of an Antimicrobial Peptide, Nisin ZP, for Non-Small Cell Lung Cancer (NSCLC) Treatment

(T1130-04-22) Preparation and Evaluation of 2D Printing Controlled Release Film Containing Fine Dose Theophylline

(W1130-04-22) Preparation and Evaluation of Choline Alfoscerate Sustained Release Coated Soft Capsule Using the Controlled Osmotic Pump System

(T1130-04-23) Development of a Low-Dose Pilocarpine Ophthalmic Formulation that is Stable, Well-Tolerated and Bioavailable at a Near-Neutral pH for the Treatment of Presbyopia

(W1130-04-23) The Effect of Surfactants and pH Modifying Agents on the Dissolution and Permeation of Pimobendan

(T1130-04-24) A Potential Mechanism of Tabletability Flip Phenomenon

(W1130-04-24) Evaluation of Polymers for Extended-Release Formulations: Hot-Melt Extrusion Paired Fused Deposition Modeling 3D Printing

(T1130-07-37) Can an Excipient System including Magnesium Stearate Resist Mixing Times?

(W1130-07-38) Investigation of Physical Stability of Coamorphous Systems at Elevated Temperature and Humidity Conditions

(T1130-07-38) The Influence of the Chiral Coformer Tryptophan on the Physical Stability of Co-amorphous Systems with Indomethacin as Model Drug

(M1130-07-40) The Effects of 3D-Printing Polyhedron Mini-tablets and Their Drug Delivery Kinetic Models

(M1130-07-41) Optimization of Novel Platinum Based Cyanide Scavengers: In Vitro Prioritization

(M1130-07-42) Fabrication of a Core-Shell Model for Combinational Drug Delivery via Hot Melt-Extrusion Paired with 3D Printing

(M1130-12-67) Anti-SARS-CoV-2 Nasal Powders: Manufacturing, Ex Vivo Drug Accumulation/Transport in Rabbit Nasal Mucosa and In Vitro Virus Inhibition

(T1130-12-70) Development and Evaluation of Polyvinylpyrrolidone and Chitosan-Based Film Forming Gel containing Acyclovir

(W1130-12-70) Development of a Donepezil Dry Powder Formulation for Enhanced Nasal Mucosa Permeation

(W1130-12-71) A Preclinical Solution Formulation Development with the Fundamental Understanding of Salt Solubility

(W1130-12-72) In Vitro Evaluation of an Extended Released Methylphenidate Hydrochloride Product Sprinkled on Food Vehicles

(T1130-12-72) Structures of Glasses Created by Multiple Kinetic Arrests

(T1230-01-01) Developing a Stable Model Formulation to be Used as a Platform Technology for BCS Class II and IV Hydrophobic Molecules with Log P >3 while Using an Aprotic Solvent System as a Solubilizer and Carrier

(T1230-01-03) Identification of Critical Spray-Drying Process Parameters for Preparing Size Tunable Microparticles using Polyvinyl Pyrrolidone and Sodium Alginate

(T1230-01-04) Enteric Coating of an Amorphous Solid Dispersion: An Emerging Strategy to Enhance the Dissolution Performance in Stimulated Gastrointestinal Fluids

(T1230-01-05) Charcoal Drug Adsorption Efficiency in Various Solvents

(M1230-01-05) Digital Light Processing (DLP) 3D Printed Tablets and Its Pharmacokinetic Evaluation in Rats

(W1230-01-05) Early-Stage Polymer Selection in Development of Stable Amorphous Solid Dispersion by Integrating Molecular Dynamics Simulation and Experimental Techniques

(M1230-03-13) A Heat-Shielded Abuse Deterrent Formulation

(T1230-03-16) How to Improve in Solubility of Water-Insoluble Cyclic Peptide with HA Nanogel : Over 100,000-Fold Solubilization

(T1230-03-18) Development of a UV Imaging Method for Characterization of Intra-Tumoral Injectables Using cAMP as Model Substance

(T1230-04-19) Insights into the Impact of Interplay of Drug Loading and Buffer Capacity on the Release of Hydroxypropyl Methyl Cellulose Acetate Succinate (HPMCAS)-Based Dispersions

(T1230-04-21) In Vitro Cytotoxicity and Biodistribution Study of Oxaliplatin-Loaded Multivesicular Liposomal Depot

(M1230-04-22) Food Effect Risk Assessment in Preformulation Stage Using Material Sparing µFLUX Methodology

(M1230-04-23) Formulation Design, Characterisation and In Vivo Performance of Self-Emulsifying Drug Delivery Systems (SEDDS) for a BSC Class II NCE

(M1230-04-24) Comparison of Mucociliary Clearance Rates of Bioadhesive Gels, Powders and Spray-Dried Polymeric Microparticles

(M1230-07-38) Assessing the Interrelationship of Microstructure, Properties, Drug Release Performance, and Preparation Process for Amorphous Solid Dispersions

(T1230-07-39) Application of Film Coating Systems to Hide Dark Spots on Multivitamin Tablets

(M1230-07-39) Impact of Modulating HPMC Properties on Modified Released Matrix Formulation of a High Dose Drug

(T1230-07-40) Investigation of the Impact of Manufacturing Parameters on the Mechanism of Formation of Naltrexone-PLGA Microparticles with SSNMR

(W1230-07-40) Preparation of Highly Soluble Anti-tubercular Salt: Clofazimine mesylate

(T1230-07-41) How to Maintain Drug Stability During Twin-Screw Melt Granulation

(W1230-07-41) Solubility Measurement and Modeling of Various Drugs in Binary Solvent Mixtures at Different Temperatures

(T1230-12-69) Impact of Aluminum Oxide Nanocoating on Release Behavior of Posaconazole/HPMCAS Amorphous Solid Dispersions

(M1230-12-70) Cyclodextrin Inclusion Complex of Novel Anti-mycobacterial Compound

(T1230-12-71) pH Impact on the Suspension Capability of Colloidal MCC

(M1230-12-72) Optimizing the Synthesis and Performance of Amorphous Drug-Polymer Salts through Acid-Base Reactions: an X-ray Photoelectron Spectroscopy Study

(M1330-01-03) Design and Optimization of Lornoxicam Dispersible Tablets Using Quality by Design Approach

(T1330-01-05) Augmenting In Vitro Dissolution of a Poorly Soluble API with a Multifunctional Lipidic Surfactant in an Orally Disintegrating Tablet

(M1330-01-05) Creation and Utilization of Polymer “Alloys” to Increase Drug Loading and Dissolution Performance of Ivacaftor Amorphous Solid Dispersion

(T1330-01-06) Scaled-Up Production of High Drug Loading and Dissolution Enabling Lumefantrine Granules

(T1330-03-14) Study on the Impact of Tablet Compression Parameters for a Directly Compressible Formulation Containing Model Low Dose API

(M1330-03-16) pH-Independent Modified Release Matrix Tablet of Weakly Basic Drug Using Acidic Ionizable Polymer

(M1330-03-17) Alternative Methotrexate Oral Formulation: Enhanced Aqueous Solubility, Bioavailability, Photostability, and Permeability

(M1330-03-18) Study of the Physiochemical Characteristics of Luteolin for Application in (Trans)Dermal Delivery

(M1330-04-19) Mechanistic Understanding of the Impact of Ionic Interactions between Drug and Polymer on HPMCAS-Based Amorphous Solid Dispersion Performance

(T1330-04-22) N-acetylcysteine-Loaded Magnetite Chitosan Microparticle (NMCP) Part Ⅱ: In Vitro and In Vivo Study to Confirm the Nitrate Adsorption Behavior

(T1330-04-23) Amorphous Powder for Nasal Delivery: Intranasal Naloxone Powder for Treating Opiod Overdose

(T1330-04-24) Preparation and Characterization of a New Sweet Salt of Berberine

(T1330-07-37) Coexistent API-Polymer Halogen and Hydrogen Bonds in Amorphous Solid Dispersions Affect Drug Solubility and Miscibility

(T1330-07-39) Influence of Solid Content and Plasticizer in Formulation of Hypromellose Oral Thin Film – Part 1

(M1330-07-40) Enteric Coating and Evaluation of Optimized Curcumin-Loaded Nanostructured Lipid Carriers

(M1330-07-41) Improving Dissolution Performance and Drug Loading of Amorphous Dispersions Through a Hierarchical Particle Approach

(M1330-07-42) Development of a Theranostic Agent for Potential Diagnosis and Treatment of High-Risk Neuroblastoma in Children

(M1330-12-69) Development of Nicotine Dry Powder for Inhalation by Thin-Film Freezing

(T1330-12-70) API-Sparing KinetiSol Processing Approach to Support Discovery Chemistry

(M1330-12-71) Application of Avicel® as Cushioning Agent in MUPS Tablets

(T1330-12-71) Quality and Processability Parameters Prediction for a Direct Compressible Tablet Powder Mix

(T1330-12-72) Investigation of Polymers for SLS 3D-Printing of Solid Oral Dosage Forms

(T1430-01-01) Development of Sublingual Tablets Containing Promethazine Hydrochloride for Paediatric Applications

(T1430-01-04) Animal Pharmacokinetic Studies of Cannabidiol Nanoformulation

(M1430-01-05) A Systematic Approach to Developing Lipid-Based Drug Delivery Systems (LBDDS) with Fenobrate as Model Drug

(M1430-01-06) Target New Therapeutics Areas from Aspirin while Using Hot Melt Extrusion as an Enabling Technology

(M1430-03-13) Investigation of Factors Influencing Drug Release from Controlled Release Hydrophilic Matrix Formulation using Central Composite Design of Experiments

(M1430-03-14) The Effect of a Clean-Label, Plant-Based Natural Glidant on the Flow Properties of Multiple Model Powders Compared to a Synthetic Glidant

(M1430-03-15) 3D Printing of Container Tablets: A New Paradigm for Multi-drug containing Bioactive Self-Nanoemulsifying Drug Delivery Systems (Bio-SNEDDS)

(T1430-03-16) Comparison of Film Coating Weight, Color Uniformity and Throughput of Tablets Coated in High Speed Semi Continuous Coater and Traditional Pan Coater Using Titanium Dioxide Free Film Coating Systems

(T1430-03-17) The Sustained Release Potential of MCM-41 versus SBA-16 Serving as Entrapment Carriers after Amine Surface Functionalization

(T1430-03-18) Application of MicroCoat^TM Technology to Mask Bitter Taste of Amodiaquine and Artesunate in a Combination Antimalarial Formulation for Oral Paediatric Administration

(M1430-03-18) Super Material-Sparing HME Screening: Simultaneous API Loading and Degradation Predictions

(M1430-04-21) Comparison of the Tendency of DC Excipients to Build-Up of Static Electricity

(M1430-04-22) Determining Critical Parameters that Predict Physical Stability of Amorphous Solid Dispersions

(T1430-04-23) Building a Chemical Space Map for In Silico Prediction of Supersaturation by Mesoporous Silica

(M1430-04-23) Evaluating pH and Buffer Effects on (-)- and (+)- Phenserine Chemical Stability

(M1430-07-37) Development of Inhalable Layer-by-Layer Assembled Particles for Small Cell Lung Cancer (SCLC) Treatment

(M1430-07-39) Treatment of Non-Tuberculous Mycobacterial Infections via Spray Dried Tigecycline Dry Powder Aerosols

(M1430-07-40) Developing Cyclodextrin-Complexed Edaravone – An Inhaled Repurposed Therapy for Idiopathic Pulmonary Fibrosis (IPF)

(T1430-07-40) Preformulation Studies on Two Novel Indole-2-Carboxamides Highly Potent Against Nontuberculous Mycobacteria

(T1430-07-41) Preparation of Telmisartan Nanoparticles by the Supercritical Antisolvent Process: Effect of Particle Size on the Dissolution and Oral Bioavailability

(M1430-07-41) The Size of the Unstirred Water Layer as a Function of Diffusion Coefficient

(T1430-07-42) Preparation and Characterization of Orally Disintegrating Tablets of Caffeine, Verapamil and Atenolol

(T1430-12-68) Inhaled Ponatinib-Cyclodextrin Complex for Anticancer Effects on Non-Small Cell Lung Cancer

(T1430-12-70) Inhaled Albumin Nanoparticles as a Delivery Strategy to Improve the Risk/Benefit Ratio of PDE-4 Inhibitors

(M1430-12-71) Evaluation on Stability of Plant Based Softgels (SeaGel® Technology) versus Gelatin Softgels

(M1530-01-03) In Vitro and In Vivo Characterization of Rapidly Dissolving Printlets of Isoniazid Manufactured by SLS 3D Printing

(T1530-01-05) Pectin as a Natural Tablet Coating Alternative

(T1530-01-06) Properties and Printability of Recycled Pharmaceutical Powder Blend in SLS 3D Printing

(T1530-03-13) Characterization of Swelling Behavior of HPMC alone and in Combination with Some Ionic Polymers

(T1530-03-15) A Comparison of Cocrystals of a Poorly Water-Soluble, Fast Recrystallizing Drug with Its Amorphous Solid Dispersions

(M1530-03-16) An Assessment of the Gastro-Resistance and Dissolution Rate of Banded and Not-Banded Capsules Coated with an Enteric Coating Film

(M1530-03-17) Impacts of Polymer Thermal Degradation on In Vitro Performance of Amorphous Solid Dispersions

(M1530-03-18) Impact of Manufacturing Processes of Supersaturation Optimized Ternary Amorphous Solid Dispersions on Solid State and Dissolution Performance

(M1530-04-19) Solubility Enhancement and Improved Efficacy of Delamanid Using Cyclodextrin Inclusion Complex

(T1530-04-22) N-acetylcysteine-Loaded Magnetite Chitosan Microparticle (NMCP) Part I: Preparation of Inhalable Chitosan-Fe₃O₄ Composite for Removal of Nitrate of Particulate Matter

(T1530-04-23) Determination of Binding Constants between Diflunisal and Trazodone and Several Excipients

(M1530-04-23) Effect of Coacervation Processing Parameters on In Vitro Drug Release from PLGA Microspheres

(T1530-04-24) Compatibility Study between Fluoroquinolones and Carbopol^® Polymers Used in the In Situ Gel Forming Delivery Systems

(T1530-07-38) Synthesizing Cisplatin Pt (IV) Derivatives for Reducing Systemic Toxicity and Enhancing Anticancer Efficacy in Triple-Negative Breast Cancer

(M1530-07-40) Investigation of Nasal Delivery System of a Prokinetic for the Treatment of Gastroparesis and Other Motility Related Disorders

(M1530-07-41) Spray Dried Combination Formulations of Tobramycin and Colistin for Pulmonary Delivery Show Excellent In Vitro Powder Aerosolization

(M1530-07-42) Discovery of a Targeted Oral Prodrug for Prostate Cancer Therapy

(M1530-12-67) Arginine Coated Self-Emulsifying Nanoglobules for Nasal Delivery of Insulin

(T1530-12-70) In Situ Phase Transition to Liquid Crystal with the GMO and Co-surfactant for Controlled Nasal Mucosa Permeation of Drug

(M1530-12-70) Reformulation of Niclosamide into Biofilm Penetrating Nanoparticles to Improve Its Repurposing for the Treatment of Candidiasis

(T1530-12-71) Development of a Fixed Dose Combinations Using Double Melt Extrusion Technology

(T1530-12-72) Dissolution Rate Increases for Morphine Sulfate Extended-Release Drug Product When Mixed with High pH Soft Food for Long Contact Times

(M0930-12-72) Co-processed Hydroxypropyl Methylcellulose–Mannitol as a Directly Compressible Excipient for Controlled Release

(T1130-07-42) Chiral Resolution by Crystallization: The Case of Arabitol

(T1430-04-24) Investigating Critical Parameters for Using Phenylarsine Oxide as a Surrogate to Assess Percutaneous Absorption of Arsenicals

(W1230-01-06) A Multi-detector Platform Combining Liquid Chromatography with High Resolution Mass Spectrometry, UV and Charged Aerosol Detection for Comprehensive Extractables and Leachables Analysis

(T0930-01-04) Sublimation Loss of Drugs from Topical Products at the Site of Application

(M0930-04-24) Developing Efficient Bioequivalence Approaches for Generic Vaginal Drug Products

(M1130-04-24) The Impact of Cyclodextrin on Fasting and Fed Bioequivalence Studies in Solid Oral Immediate-Release Drug Products

(M1230-01-06) Generic Long-Acting Injectable Product Availability and Approval Standards

(T1330-07-38) Stimulated Raman Scattering (SRS) Microscopy and Deep Learning: Novel Pharmacokinetic Approach for Evaluation of Topical Bioequivalence

(T1330-07-41) Using Different Approaches for Evaluation of Aerodynamic Particle Size Distribution Data in Cascade Impaction Test for Orally Inhaled Drug Products (OIDPs) Bioequivalence

(M1530-04-24) A Brief Review of FDA-Approved New Drug Applications Labeled with Sprinkle Administration

(M0930-06-31) Identifying Protein Aggregation through UV-Visible Absorption Spectroscopy

(T0930-06-31) Assessing the Analytical Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product

(T1230-06-33) Roadmap for Assessing Analytical Similarity: Case Study of Mab Biosimilar

(T1030-06-33) Real World Application of Deterministic, Non-destructive CCI Testing on the Entire Batch (100%) - Not a Concept Anymore!

(W1030-06-34) Characterization of Protein Formulations to Optimize Annealing Parameters for Freeze-Drying

(M1030-08-43) Quality Assurance Practices for Transportation of Oncology Treatments: The Case Study of Drones

(W1130-06-31) Evaluating Strategies to Minimize Leakage of Protein from Ethylcellulose Microcapsules Using Bovine Serum Albumin as Model Protein

(M1130-06-31) Impact of Freezing Process Parameters on Jurkat Cell Cryopreservation

(T1130-06-32) Solid-State Stabilization of Proteins in Highly-Loaded Melt Extrudates – Characterization of Protein Integrity

(T1330-06-31) Development of Cell-Based Bioassays for Measuring the Potency of Biological Drug Products

(M1330-06-31) Residual Moisture Influences Virus Stability in a Film Based Dosage Form for Long-Term Stability of Biologics

(T1330-08-44) Feasibility of Spray Drying Biotherapeutics: A Material Sparing Screening Process

(T1430-06-31) Development of a Lyophilized Single Vial Adjuvanted Sub-unit Vaccine for Bed Side Reconstitution

(M1430-06-35) Compatibility of BiTE® (Bispecific T-cell Engager) Drug Product with Manufacturing Materials

(T1430-08-47) Engineering 3D Printed Microfluidic Chips for the Fabrication of Nanomedicines

(T1530-06-32) Immunogenicity Risk Assessment for Host Cell Proteins in Vaccines and Biologics

(W0930-08-43) A Survey of Biological License Application of Monoclonal Antibodies – Part I: Types and Timing of Manufacturing Changes

(M0930-08-47) Microalgae as Cell Factories for Antiviral Protein Production

(T1030-08-43) An Efficient HEK293 Cell Line for Scalable, GMP-Ready Production of Adeno-Associated Viral Vectors

(M1130-08-43) Final Sterile Filtration of Lentivirus

(M1130-08-46) Purification and Heat Inactivation of an Oxidation Prone Protein: Study of Hemoglobin

(M1230-08-43) A Survey of Biological License Application of Monoclonal Antibodies – Part II: Comparability Approaches for Manufacturing Changes

(T1130-08-43) Peptide Mapping of Monoclonal Antibody (mAb) Using an Integrated Online Protein Digest LCMS Platform

(M1430-08-43) Impact of Freezing Rate on Lyophilization Primary Drying Efficiency and Porous Structure: Comparison of Three Measurement Techniques

(W1030-08-44) Automated and Centralized Buffer Management for Downstream Processing in Biopharmaceutical Manufacture

(M1430-08-47) Accurate Bulk Filling for an Automated and Flexible Drug Substance Manufacture

(W0930-06-32) Applying Quality by Design Principles to the Migration of a Compendial Method between Multiple HPLC Systems

(T0930-06-32) Assessing Key Attributes of Adeno-Associated Viral Proteins Using HPLC-FLD-Intact Accurate Mass Analysis

(M0930-06-32) Method for the Analysis and Quantitation of Pharmaceutical Counterions Utilizing Hydrophilic Interaction Liquid Chromatography

(T0930-06-33) Impact of Apparatus and Adaptor Setups on In Vitro Drug Release of Ophthalmic Semi-solid Drug Products

(M0930-06-33) Wavelength Selection Method Based on Partial Least Square for Determination of Quetiapine in Tablets

(T0930-06-35) Automated Adaptive Perfusion: A Novel In Vitro Drug Release Testing System for Complex Drug Products

(W0930-08-44) Effect of Moderate Biorelevant Increases in Medium Viscosity on the Dissolution Rate of Ibuprofen Particles

(T0930-08-44) LC-PDA and a Multivariate Curve Resolution – Alternating Least Square Algorithm for Identification and Quantification of Co-eluting Impurities in Pharmaceutical Analysis

(M0930-08-45) Use of Predictive Dissolution to Guide Formulation Development - A Case Study of a Weak Base Drug in Conventional and Enabled Oral Formulations

(W0930-08-47) Impact of Change in Test Conditions on Alginate Raft Strength

(T1030-06-31) Strategies for Correcting Peak Fronting of Oxycodone Hydrochloride, Naloxone Hydrochloride and Related Substances Observed in Reversed—Phase Liquid Chromatography

(T1030-06-32) Characterization and Quantification Analysis of Onivyde Irinotecan Liposome Injection

(W1030-06-32) Probing Microenvironmental Acidity in Pharmaceutical Frozen Solution Using Solid-State NMR Spectroscopy

(M1030-06-35) Physicochemical Characterisation of Piroctone Olamine for Topical Delivery to the Skin

(T1030-08-44) Effect of Coating of Andersen Cascade Impactor and Next Generation Impactor on the Aerodynamic Particle Size Distribution of Nine Commercial Metered Dose Inhalers

(M1030-08-44) Probing Surface Chemical Analysis of Banana Starches in Functional Applications

(W1130-06-32) In Vitro Model to Study the Lymphatic Voyage of Drugs via Artificial Chylomicrons

(M1130-06-32) Investigating Pharmaceutical Frozen Solution Using 31P and ¹H Solid-State NMR

(T1130-08-45) Automating Analytical Method Development with LabSolutions MD: Separating Cannabinoid Stereoisomers using Analytical Quality by Design (AQbD) Principles from ICH Q2(R2) and ICH Q14

(T1130-08-47) Building Fundamental Understanding of Drug Release Mechanisms via Release of Functional Excipients

(M1230-06-31) Development and Validation of a Stability Indicating UPLC-DAD Method For The Simultaneous Determination of Praziquantel and Ivermectin In 57/0.18 mg Pharmaceutical Tablets and Dissolution Samples.

(M1230-06-32) Improve NTA Measurement Repeatability with Correct Diluent

(T1230-06-32) Intentionally Made Amorphous Substance to Quantify Unintentionally Produced Amorphous Materials: Decades of Hands-On Experience

(T1230-06-34) Characterization and Comparison of Biorelevant Simulated Airway Mucus Models to Improve the Development of In Vitro Dissolution and Diffusion Assays for Aerosols

(T1230-08-45) Multiscale Thermo-Kinetic Aging Model of Complex Systems: Application to Device Materials and Interfaces including Implications in Drug Stability

(T1330-06-32) Identification and Control Strategy of Diastereomer Impurities in API Produced via Biocatalytic Cascade

(M1330-06-32) Reducing Environmental Bias in Measurements of Plume Geometry for Pressurized Metered-Dose Inhalers (pMDIs)

(M1330-08-45) Quality by Design Approach of Chiral Method Development of Compound E

(T1330-08-46) Compendial Strategy to Update Asbestos Testing Methods for Quality Control of USP Talc

(M1330-08-47) Optimization of HPLC Method for Impurities Determination of Chromophore Molecule to Solve an Anomalous Carry Over Issue

(M1430-06-31) Feasibility of Synchrotron XRD for the Analysis of Mixture Sub-samples

(M1430-06-33) Use of PAT Tools in the Development, Monitor and Control of Continuous Manufacturing Processes

(T1430-06-34) Chemical Imaging by Raman Spectroscopy: A Powerful Analytical Technique for Surface Morphology Investigation of Inhaled Products

(T1430-06-35) Investigation of In Vitro Buccal Permeation Mechanisms of Compound A

(T1430-08-43) Rapid Residual Solvent Analysis using SIFT-MS for USP Method < 467 >

(T1430-08-46) Using Raman Mapping to Detect and Identify Challenging Degradation Products and Complex Drug-Drug Interactions in a Tablet

(M1530-06-32) Considerations and Impact of Extra-Column Volume on the Analysis and Scaling of a HPLC Separation

(M1530-06-35) Paper-Based Fluorophores and Machine Learning: A Versatile Tool for Accurate Identification of Pathogenic Bacteria

(M1530-08-43) Photo-Oxidation Mechanisms in Liquid Formulations: Thinking beyond Peroxide and Free Radical Induced Degradation

(M1530-08-44) At Line Near Infrared Quantification of Alpha – Tocopherol in Process Production of Vitamin E Soft Gelatin Capsule

(W0930-06-33) Increased Spray Rates for Particulate Coating Using Wurster Pro Technology

(W0930-06-34) Explaining Deviant Behaviors in the Tabletability of Mixtures

(M0930-06-34) Stability of Medications Used by Qatar’s Ambulance Service in Rapid Response Vehicles: Protocol Development

(M0930-08-44) Accelerated Technology Transfer for the Development and Commercialization of Fexuprazan Using Compaction Simulation

(T0930-08-45) Effect of Die Taper and Precompression on Air Entrapment during Tablet Compression

(W1030-06-31) Small Scale, Rapid Prototyping of Hydralese™ (PGSU) (poly(glycerol sebacate) urethane) Microdevices for Controlled Drug Delivery in Ocular Implants

(M1030-06-32) Aerodynamic Performance of Spray Dried Cannabidiol Powder for Efficient Pulmonary Delivery

(T1030-06-35) A Systematic In Vitro Study to Evaluate Age-Appropriate Oral Administration Routes for Clinical Pediatric Delivery of an Oral Granules Formulation

(M1030-08-45) Novel 3D Printed Modular Tablets containing Multiple Anti-viral Drugs: High Precision Drop-on-Demand Drug Deposition

(T1030-08-45) Tribological Response of Hydroxyethyl Cellulose Gels as a Function of Isopropyl Alcohol Concentration and Angular Velocity Profile

(T1130-06-31) Stability of 0.9% Sodium Chloride IV Fluid Bags in the Prehospital Setting of Qatar: Protocol Development

(M1130-06-33) Continuous Manufacturing of Inhalation Powders: Effects of Processing Parameters

(T1130-06-33) Midazolam Buccal Films: Development and Characterization for Palliative Care

(W1130-06-33) Reducing Degradation of a Ritonavir Amorphous Solid Dispersion by Managing Melt Temperature in a Twin Screw Extruder

(T1130-06-34) Impact of Formulation Processes on Dosage Form Determination of Phytonadione Injectables

(T1130-08-44) Dexamethasone Intravitreal Implants: Manufacture, Characterization, and Elucidation of Drug Release Mechanisms

(M1130-08-45) Predicting Tablet Properties Using In-Line Measurements and Evolutionary Equation Discovery

(T1230-06-31) Transforming Multi-particle Populations with Normal Size Distribution into Mega Beads with Discrete Sizes and Precise Drug Strengths: Surface Area and Rate of Drug Deposition as Critical Parameters

(T1230-08-43) In Vitro Assessment of Cooling Potential of the Topical Gel System and Influence of Inactive Ingredients

(M1230-08-44) Case Study Approach for API Mechanical Properties Evaluation on Oral Solid Dosage Forms Development

(M1330-06-33) Encapsulation of a Common Blend Formulation Using an Automatic Encapsulator: A Study on the Effect of Fill Weights on Weight Variation and Dissolution Behavior

(T1330-06-33) Extensive Characterization of Spray Dry Solution Atomization for HPMCAS Placebo Solutions by Optical Patternation, Phase Doppler Analysis, and Spray Velocity

(M1330-06-34) Significance of Drug Excipient Compatibility Studies in Topical Drug Product Development

(T1330-08-43) Interaction Effects of Wet Granulation Process Parameters on Granule Size and Dissolution Performance of a High Drug Load Product Manufactured in a High-Shear Mixer

(M1330-08-46) Impact of Material Attributes and Critical Process Parameters on Low Dose Powder Filling Using Drum Filler System

(M1330-08-48) Quantification and Identity Testing of Soft Gel Capsules using Transmission Raman Spectroscopy

(T1330-08-48) Titanium Dioxide Free Color Mixtures for Use in Pharmaceutical Drug Products: A Manufacturing Performance Evaluation of the Alternatives

(T1430-06-33) Downstream Processing of Itraconazole:HPMCAS Amorphous Solid Dispersion: From Hot-Melt Extrudate to Tablet Using a Quality by Design Approach

(M1430-06-34) Application of a Population Balance Equation Based Wet Bead Milling Model to Process Design and Scale-Up of a Long Acting Injectable Formulation

(T1430-08-44) Application of Machine Learning Tools for Predicting Impact of Punch Cup Depth on Tablet Capping

(T1430-08-48) Customized Fast-Dissolving Orodispersible Films Using Extrusion-Based 3D-Printing

(M1530-06-33) Dimensional Conformity of Filaments in Hot-Melt Extrusion: Design of Experiment and Process Optimization

(T1530-06-33) Gradient Recycling Chromatography for the Preparation of Pure Target Compounds Present in Highly Complex Mixtures

(T1530-06-34) Seeing is Believing: A Microscopic “Google Earth” View of Extended-Release Claritin Formulation

(M1530-08-45) Tracking of Environmental Factors within Qatar’s Ambulance Service Settings: A Pilot Study

(M1530-08-47) Air Entrapment during Tablet Compression – Diagnosis and Impact on Tableting Performance Assessed with a Compaction Simulator

(T1330-06-34) A Powder Tabletability Equation

(M1030-06-34) Experimental and Theoretical Investigation of Rotary Atomization Dynamics for Control of Lipid Multiparticulate (LMP) Particle Size during Spray Congealing Process

(T1030-08-46) Factors to Consider for Increasing HPLC Column Lifetime